<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27917862</article-id><article-id pub-id-type="pmc">5137030</article-id><article-id pub-id-type="pii">srep37819</article-id><article-id pub-id-type="doi">10.1038/srep37819</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dehghan</surname><given-names>Firouzeh</given-names></name><xref ref-type="corresp" rid="c1">a</xref><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Soori</surname><given-names>Rahman</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gholami</surname><given-names>Khadijeh</given-names></name><xref ref-type="aff" rid="a2">2</xref></contrib><contrib contrib-type="author"><name><surname>Abolmaesoomi</surname><given-names>Mitra</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Yusof</surname><given-names>Ashril</given-names></name><xref ref-type="aff" rid="a4">4</xref></contrib><contrib contrib-type="author"><name><surname>Muniandy</surname><given-names>Sekaran</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Heidarzadeh</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="a5">5</xref></contrib><contrib contrib-type="author"><name><surname>Farzanegi</surname><given-names>Parvin</given-names></name><xref ref-type="aff" rid="a6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ali azarbayjani</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="a5">5</xref></contrib><aff id="a1"><label>1</label><institution>Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tehran</institution>, Tehran, <country>Iran</country></aff><aff id="a2"><label>2</label><institution>Department of Physiology, Faculty of Medicine, University of Malaya</institution>, 50603 Kuala Lumpur, <country>Malaysia</country></aff><aff id="a3"><label>3</label><institution>Department of Molecular Medicine, Faculty of Medicine, University of Malaya</institution>, 50603 Kuala Lumpur, <country>Malaysia</country></aff><aff id="a4"><label>4</label><institution>Department of Exercise Science, Sports Centre, University of Malaya</institution>, 50603 Kuala lumpur, <country>Malaysia</country></aff><aff id="a5"><label>5</label>Department of Exercise Physiology, Central Tehran Branch, Islamic Azad University, Tehran, Iran</aff><aff id="a6"><label>6</label>Department of Exercise Physiology, Sari Branch, Islamic Azad University, Sari, Iran</aff></contrib-group><author-notes><corresp id="c1"><label>a</label><email>fir_dhn@yahoo.com</email> or <email>firouzeh.dehghan@ut.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id>37819</elocation-id><history><date date-type="received"><day>08</day><month>04</month><year>2016</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, The Author(s)</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p>The aim of this study was to investigate the responses of atherosclerosis plaque biomarkers to purslane seed consumption and aerobic training in women with T2D. 196 women with T2D were assigned into; (1) placebo (PL), (2) aerobic training+placebo (AT&#x02009;+&#x02009;PL), 3) purslane seeds (PS), aerobic training+purslane seeds (AT&#x02009;+&#x02009;PS). The training program and purslane seeds consumption (2.5&#x02009;g lunch and 5&#x02009;g dinner) were carried out for 16 weeks. The components of purslane seed were identified and quantified by GC&#x02013;MS. Blood samples were withdrawn via venipuncture to examine blood glucose, low-density lipoprotein (LDL), high-density lipoprotein (HDL), cholesterol, triglycerides (TG), creatinine, urea, uric acid, NF-&#x003ba;B, GLP1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS expressions. Blood glucose, LDL, cholesterol, TG, creatinine, urea, and uric acid levels in the (P), (AT), and (AT&#x02009;+&#x02009;PS) groups were significantly decreased compared to the pre-experimental levels or the placebo group, while HDL, significantly increased. Furthermore, the protein and mRNA levels of NF-&#x003ba;B, TIMP-1, MMP2 &#x00026;9, CRP, CST3, and CTSS in the (P), (AT), (AT&#x02009;+&#x02009;PS) significantly decreased compared to pre-experimental or the placebo group, while level of GLP1 and GLP1-R increased drastically. Findings suggest that purslane seed consumption alongside exercising could improve atherosclerosis plaque biomarkers through synergistically mechanisms in T2D.</p></abstract></article-meta></front><body><p>Diabetes mellitus (DM) is a metabolic disease with 8% worldwide prevalence in 2011 whereby it&#x02019;s prevalence estimated to reach 10% by 2030<xref ref-type="bibr" rid="b1">1</xref>. DM is characterized by hyperglycemia, glucose intolerance, abnormal lipid and protein metabolisms along with specific long&#x02013;term complications affecting several major organs, including heart, blood vessels, nerves, eyes, and kidneys. Diabetic complications, such as cardiac dysfunction, atherosclerosis, neuropathy, retinopathy, and nephropathy<xref ref-type="bibr" rid="b2">2</xref><xref ref-type="bibr" rid="b3">3</xref> are linked to defective insulin secretion, insulin resistance, or both<xref ref-type="bibr" rid="b4">4</xref><xref ref-type="bibr" rid="b5">5</xref>. Patients with type 2 diabetes (T2D) are at higher risk of complications arising from macro vascular, peripheral vascular and coronary heart disease, stroke, and insulin resistance associated with atherosclerosis<xref ref-type="bibr" rid="b6">6</xref>.</p><p>Atherosclerosis is a chronic inflammatory disease of blood vessels and it is characterized by formation of atherosclerotic plaques in arteries including calcified regions, necrotic cores, inflamed smooth muscle cells, accumulated modified lipids, endothelial cells, leukocytes, and foam cells<xref ref-type="bibr" rid="b7">7</xref>. Atherosclerosis causes cardiovascular diseases (CVD) in the components of the vascular, immune systems are involved<xref ref-type="bibr" rid="b8">8</xref>. Atherosclerosis diagnosis comprises of the identification of biomarkers linked to the development of this disease. Among the markers, nuclear factors kappa beta (NF-&#x003ba;B) and C-reactive protein (CRP) are the master key and prototypic markers respectively<xref ref-type="bibr" rid="b9">9</xref><xref ref-type="bibr" rid="b10">10</xref>. Activation of NF-&#x003ba;B is a key event in the pathobiology of diabetes and leads to apoptosis of beta cells. It is required for the transcription of inflammatory molecules containing adhesion molecule, cytokine and chemokines<xref ref-type="bibr" rid="b11">11</xref>. Matrix metalloproteinases (MMP) and cysteine proteases degrade extracellular matrix (ECM) proteins which are essential for vascular remodeling thus contributing to CVD<xref ref-type="bibr" rid="b12">12</xref><xref ref-type="bibr" rid="b13">13</xref><xref ref-type="bibr" rid="b14">14</xref>. High levels of glucose, LDL, VLDL, and uric acid activate CRP and NF-&#x003ba;B pathways which increase the expression of MMP2, MMP9 and CTSS (<xref ref-type="fig" rid="f1">Fig. 1</xref>)<xref ref-type="bibr" rid="b15">15</xref><xref ref-type="bibr" rid="b16">16</xref><xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b18">18</xref>. In addition, glucagon like peptide &#x02212;1 (GLP-1) is an insulinotropic agent which improves beta cell functions<xref ref-type="bibr" rid="b19">19</xref> and protects heart muscle cells against adverse cardiac remodeling<xref ref-type="bibr" rid="b20">20</xref>.</p><p>Maintaining a healthy life style with regular physical activity has shown to reduce complications resulting from T2D<xref ref-type="bibr" rid="b21">21</xref>. In recent years, attention has been given to alternative medicines such as herbal remedies for treating and preventing plenty different diseases such as T2D<xref ref-type="bibr" rid="b22">22</xref><xref ref-type="bibr" rid="b23">23</xref>. <italic>Portulaca oleracea</italic> commonly known as purslane, is an herb from the Portulacaceae family with anti-diabetic properties<xref ref-type="bibr" rid="b5">5</xref> and has been used for therapeutic purposes. It is listed by in the World Health Organization as one of the most used medicinal plants termed as &#x02018;Global Panacea&#x02019;<xref ref-type="bibr" rid="b24">24</xref>. <italic>P. oleracea</italic> is an excellent source of antioxidants such as vitamins A, C, E and &#x003b2;-carotene<xref ref-type="bibr" rid="b25">25</xref><xref ref-type="bibr" rid="b26">26</xref>. Several studies have indicated purslane extract as a factor in lowering blood sugar, triglycerides, total cholesterol, high-density-lipoprotein (HDL), low-density-lipoprotein (LDL) and body weight in diabetic rat and mice<xref ref-type="bibr" rid="b27">27</xref><xref ref-type="bibr" rid="b28">28</xref>. Moreover, consumption of purslane seeds alongside 8 weeks of resistance training by women with T2D, improved indicators associated with liver damage<xref ref-type="bibr" rid="b29">29</xref>, proxidant and antioxidant balance<xref ref-type="bibr" rid="b30">30</xref> and blood pressure<xref ref-type="bibr" rid="b31">31</xref>. It also prevented exercise-induced oxidative stress<xref ref-type="bibr" rid="b30">30</xref>.</p><p>Physical activities such as resistance training promote an increase in lean muscle mass, muscle strength, the basal metabolic rate and sensitivity to insulin in diabetic individuals<xref ref-type="bibr" rid="b32">32</xref>. Regular exercising affects the regulation of enzymatic antioxidants such as catalase, super oxide dismutase and non-enzymatic antioxidants including vitamin E and C. Regular exercise is linked to CRP reduction, lipid profile regulation, increase of nitric oxide synthase, improvement in insulin sensitivity, and preservation of beta cell mass. Thus regular exercise leads to the adaptation in antioxidant capacity, protecting cells against harmful effects of oxidative stress<xref ref-type="bibr" rid="b33">33</xref>.</p><p>In this study our aim was to investigate the responses of atherosclerosis plaque biomarkers to purslane seed consumption (as non-medical intervention) along with aerobic training in women with T2D within a 16 week time period. We evaluated the lipid profile as well as traditional biomarkers and other biomarkers related with tissue inflammation and inflammatory response in diabetes patients including MMP 2&#x00026;9, CRP, cystain C, creatinine, uric acid.</p><sec disp-level="1"><title>Patients and Methods</title><sec disp-level="2"><title>Subject recruitment</title><p>The study involved 196 women with type 2 diabetes whose fasting blood glucose levels were greater than 200&#x02009;mg/dL (not taking metformin) and were diagnosed with the illness for an average of 8 years. The patients were on metformin with the dose of 500&#x02009;mg/day and were registered with Tehran Hospital (Iran). Characteristics and demographics of the patients are presented in <xref ref-type="table" rid="t1">Table 1</xref>. The average age and BMI of these women were 52.08&#x02009;&#x000b1;&#x02009;3.45 years and 29.5&#x02009;&#x000b1;&#x02009;6.5&#x02009;kg/m<sup>2</sup> respectively. Eligible participants lacked any form of complications arising from acute and chronic diabetes and did not exercise regularly. The participants did not have any history of other diseases such as chronic cardiovascular and inflammatory diseases, diabetic ulcers, and hepatitis. Patients consuming vitamins and supplements or those who smoked were excluded from the study. Patients were well informed about the study prior to the experiment and written consent was obtained from them. A double-blind study method was applied and the participants were randomly assigned into 4 groups of 8; (1) placebo (PL), (2) aerobic training + placebo (AT&#x02009;+&#x02009;PL), (3) purslane seeds (PS), and (4) aerobic training + purslane seeds (AT&#x02009;+&#x02009;PS). All procedures involving experiments were carried out in strict accordance of the United States Institute of Research guidelines and approved by the Medical Centre Board of Tehran Hospital with Medical Ethics Number 4382.30.</p></sec><sec disp-level="2"><title>Plant sample preparation</title><p>Purslane seeds were purchased from a grocery shop in Tehran (Iran). The seeds were washed and air dried at room temperature for seven days. The dry seeds were powdered and packaged in capsules (5&#x02009;g each). <italic>Portulaca oleracea</italic> was identified and verified by a botanist and deposited at Herbarium of Department of Biochemistry, (voucher specimen no. 15&#x02013;04979). The consumer groups (AT&#x02009;+&#x02009;PS, PS) consumed 2.5&#x02009;g of purslane seeds with lunch and 5&#x02009;g with dinner daily for 16 weeks. The placebo group similarly received placebo pills (the flavored maltodextrin).</p></sec><sec disp-level="2"><title>Sample preparation and identification of compounds by Gas Chromatography/Mass Spectroscopy (GC/MS/MS)</title><p>Dried powdered (100&#x02009;g) purslane seed was added with 100&#x02009;ml of methanol and left at room temperature overnight. The eluate was filtered through Whatman filter paper and shade dried to remove the solvent. The extract was then weighed (0.563&#x02009;g) and kept in &#x02212;20&#x02009;&#x000b0;C for further analysis. The extract was used in Gas Chromatography. The detail of Chromatography is available in <xref ref-type="supplementary-material" rid="S1">supplementary file</xref>.</p></sec><sec disp-level="2"><title>Aerobic training Guideline</title><p>Patients in groups AT&#x02009;+&#x02009;PL and AT&#x02009;+&#x02009;PS performed their training under a trainer&#x02019;s supervision for 16 weeks in a gym. The trainer is blinded to the subject&#x02019;s treatment group. Jogging was considered for this study as a moderate-intensity aerobic activity. Progressive training was performed for a minimum of 60&#x02009;min per session for three days a week at 50 to 70% of maximum heart rate (MHR) during the 16 weeks of experiment. Written informed consent was obtained from all patients before any study-related procedures were performed. Patients were familiarized with the protocol and a heart rate strap was applied on them to monitor their heart rate within the first two sessions. The training included a 15&#x02009;min warm-up through walking with light static and dynamic stretching and cooling down with stretching in standing and lying position in the final 15&#x02009;min. All movements were performed with medium tempo and separate movement for arms, legs and trunk. The main training time increased 40 to 45&#x02009;min and heart rate has reached 70% MHR. At the end of 16 weeks participants were able to perform muscle movements with greater coordination.</p></sec><sec disp-level="2"><title>Blood Sample Collection</title><p>Blood samples were collected at the certain time of the trainings through the elbow antecubital vein of all patients, 24&#x02009;hours before and after the 16 weeks training and purslane consumption for measurement of blood glucose, LDL, HDL, cholesterol, TG, creatinine, urea, uric acid, NF-&#x003ba;B, GLP1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS mRNA and protein expressions.</p></sec><sec disp-level="2"><title>Measurement of Serum parameters</title><p>Blood samples were collected in serum separating tubes (SST) and allowed to clot at room temperature for 30&#x02009;min. The blood clot was then centrifuge at 3000&#x02009;g for 15&#x02009;min. Aliquots of the serum samples were stored at &#x02212;20&#x02009;&#x000b0;C for further use. Fasting serum glucose and total cholesterol levels were determined using the glucose oxidase method<xref ref-type="bibr" rid="b34">34</xref> with a digital spectrophotometer (Spectronic, US). LDL level was calculated using the Friedewald equation<xref ref-type="bibr" rid="b35">35</xref>, and to measure HDL level, diagnosis kits were used following the photometric method. Serum triglycerides was measured by using the Fossati and Prencipe method<xref ref-type="bibr" rid="b36">36</xref>. Based on manufacturer&#x02019;s instructions of Fortress Diagnostics Limited, creatinine, urea, and uric acid were examined by alkaline picrate method, urease-hypochlorite and uricase-peroxidase methods respectively.</p><p>Enzyme-linked immunosorbent assay (ELISA) was performed by using commercial kits (CUSABIO - USA) for NF-&#x003ba;B, GLP-1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS. The ELISA kits detail information are available in <xref ref-type="supplementary-material" rid="S1">supplementary file</xref>.</p></sec><sec disp-level="2"><title>RNA purification and mRNA Expression Analysis by Real Time PCR (qPCR)</title><p>QIAamp RNA Blood Mini Kit (Qiagen, Germany) was used to isolate total cellular RNA from fresh whole blood. The concentration and purification of isolated RNA were evaluated by 260/280 UV absorption ratios (Gene Quant 1300, UK). Specific amplification fragments of DNA/RNA, Two-step Real time qPCR (quantitative Polymerase Chain Reaction) technique was used to calculate gene expression during the PCR amplification process with application of TaqMan reagent. This method was able to detect small differences between samples compared to other methods<xref ref-type="bibr" rid="b37">37</xref>. All reagents including probes and primers were obtained from Applied Biosystems, USA. TaqMan probe (known as fluorogenic 5&#x02032; nuclease) was chosen to perform qPCR. This probe has a sensitivity of 100% and a specificity of 96.67%<xref ref-type="bibr" rid="b17">17</xref> and is capable of detecting as few as 50 copies of RNA/ml and as low as 5&#x02013;10 molecules<xref ref-type="bibr" rid="b18">18</xref>. The same company designed specific primers for specific targets. The primers detail information are available in <xref ref-type="supplementary-material" rid="S1">supplementary file</xref>.</p><p>All experiments were conducted in 3 biological replicates in a Step One Plus real time PCR machine (Applied Biosystems, USA). The Real time PCR program includes reverse transcription, at 48&#x02009;&#x000b0;C for 15&#x02009;min, activation of ampli Taq gold DNA polymerase at 95&#x02009;&#x000b0;C for 10&#x02009;min, denaturation at 95&#x02009;&#x000b0;C for 15&#x02009;sec and annealing at 60&#x02009;&#x000b0;C for 1&#x02009;min. Denaturation and annealing steps were performed for 40 cycles. The fold changes of each target per average of ACTB were calculated and considered as mRNA expression levels of the target gene. Data was analyzed according to Comparative Ct (2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>) method, where amplification of the target and the reference genes were measured in the sample and reference.</p></sec><sec disp-level="2"><title>Statistical Analysis</title><p>Levene&#x02019;s equality of variable assumption was applied and the results revealed no significant differences among the observations. All data were presented as mean&#x02009;&#x000b1;&#x02009;SEM. Hormone levels of each subject were analyzed by descriptive statistics. Two-way analysis of variance with repeated measure (ANOVA) was used to compare changes between groups. A Bonferroni post-hoc test was used to check for significant differences between training alone vs. purslane seeds alone vs. aerobic + purslane seeds combined. For variables with normal distribution, Pearson correlation coefficient and for non-normal distributed variable, Spearman correlation coefficient were applied. SPSS 18.0 was used in this study and p&#x02009;&#x0003c;&#x02009;0.05 was considered as statistically significant.</p></sec></sec><sec disp-level="1"><title>Results</title><sec disp-level="2"><title>Gas Chromatography/Mass Spectroscopy of Purslane Seed Extract</title><p>The components of Purslane seed were identified and quantified by GC&#x02013;MS. A total of 21 known compounds are presented in <xref ref-type="table" rid="t2">Table 2</xref>. Among these compounds, 27% are unsaturated fatty acid (linoleic and palmitoleic acid); 11.18% are phytosterols (stiotestrol), and 7.9% are saturated fatty acids (palmitic acid). Additionally, smaller amounts of unknown substances were also detected (<xref ref-type="fig" rid="f2">Fig. 2</xref>).</p></sec><sec disp-level="2"><title>Serum Biochemical Parameters Analysis</title><p>The effects of purslane seed consumption and aerobic on the serum biochemicals of diabetic women are presented in <xref ref-type="table" rid="t3">Table 3</xref>. Blood glucose, LDL, Cholesterol, and TG concentration in the (PS), (AT&#x02009;+&#x02009;PL), (AT&#x02009;+&#x02009;PS) groups were significantly decreased after 16 weeks as compared to pre-experimental levels or the (PL) (p&#x02009;&#x0003c;&#x02009;0.05). No significant differences observed between (PS) and (AT&#x02009;+&#x02009;PL) (p&#x02009;&#x0003e;&#x02009;0.05), whereas significant interactions were detected between (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05).</p><p>However, the HDL levels significantly increased in all (PS), (AT&#x02009;+&#x02009;PL), (AT&#x02009;+&#x02009;PS) groups as compared to pre-experimental levels or the (PL) (p&#x02009;&#x0003c;&#x02009;0.05). No significant differences observed between (PS) and (AT&#x02009;+&#x02009;PL) (p&#x02009;&#x0003e;&#x02009;0.05), whereas significant distinction were detected in (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05). The changes were more pronounced in (AT&#x02009;+&#x02009;PS) group.</p><p>Furthermore, Creatinine, Urea, and Uric Acid in the (PS), (AT&#x02009;+&#x02009;PL), (AT&#x02009;+&#x02009;PS) groups were significantly decreased after 16 weeks as compared to the pre experimental levels or the (PL) (p&#x02009;&#x0003c;&#x02009;0.05). No significant differences observed between (PS) and (AT&#x02009;+&#x02009;PL) (p&#x02009;&#x0003e;&#x02009;0.05), while significant distinction were detected in (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05). The reductions in levels were more pronounced in (AT&#x02009;+&#x02009;PS) group.</p></sec><sec disp-level="2"><title>Atherosclerosis Biomarkers</title><p>The effects of purslane seed consumption and aerobic on the serum protein and mRNA biomarkers changes in diabetic women are presented in <xref ref-type="table" rid="t4">Table 4</xref> and <xref ref-type="fig" rid="f3">Figs 3</xref>, <xref ref-type="fig" rid="f4">4</xref> and <xref ref-type="fig" rid="f5">5</xref>. The protein and mRNA concentration levels of NF-&#x003ba;B, TIMP-1, MMP 2 &#x00026; 9, CRP, CST3, and CTSS in the (PS), (AT&#x02009;+&#x02009;PL), (AT&#x02009;+&#x02009;PS) had significantly decreased after 16 weeks as compared to the pre experimental levels or the (PL) (p&#x02009;&#x0003c;&#x02009;0.05). No significant differences observed between (PS) and (AT&#x02009;+&#x02009;PL) in the protein and mRNA concentration levels of NF-&#x003ba;B, MMP2 &#x00026;9, CRP, CST3, and CTSS (p&#x02009;&#x0003e;&#x02009;0.05), while significant distinction were detected in (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05). In addition, a significant difference observed between (PS) and (AT&#x02009;+&#x02009;PL) in the protein and mRNA concentration levels of TIMP-1, as well as significant distinction in (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05).</p><p>Furthermore, GLP1 and GLP1-R had profoundly increased in the (PS), (AT&#x02009;+&#x02009;PL), (AT&#x02009;+&#x02009;PS) as compared to the pre experimental levels or the (PL) (p&#x02009;&#x0003c;&#x02009;0.05). No significant difference observed between (PS) and (AT&#x02009;+&#x02009;PL) in the protein and mRNA concentration levels of GLP1-R (p&#x02009;&#x0003e;&#x02009;0.05), while a significant difference observed between (PS) and (AT&#x02009;+&#x02009;PL) in the protein and mRNA concentration levels of GLP1 (p&#x02009;&#x0003c;&#x02009;0.05). Moreover, significant distinction were detected in the protein and mRNA concentration levels of GLP1 and GLP1-R in (PS) and (AT&#x02009;+&#x02009;PL) compared to (AT&#x02009;+&#x02009;PS) (p&#x02009;&#x0003c;&#x02009;0.05). The changes were more pronounced in (AT&#x02009;+&#x02009;PS) group.</p></sec></sec><sec disp-level="1"><title>Discussion</title><p>The control and treatment of diabetes and its complications predominantly depends on chemical or biochemical agents. However, total recovery from diabetes has never been reported<xref ref-type="bibr" rid="b38">38</xref><xref ref-type="bibr" rid="b39">39</xref>. The data from the current study showed that 16 weeks of aerobic training or purslane seed consumption ere effective in reduction of markers of inflammations such as NF-&#x003ba;B, CRP, CST3, CTSS, MMP 2 &#x00026; 9 and TIMP-1 in diabetic patients. In addition, glucose, TG, LDL, urea, uric acid and creatinine levels in all treated groups were significantly reduced. Furthermore, there was an increase in the levels of HDL, GLP-1 and GLP-1R. The improvement was more remarkable in women who received training and supplementation simultaneously. The changes in the level of biomarkers were further evaluated by the expression of mRNA from blood samples of the same subjects. Our results show that the mRNA levels of NF-&#x003ba;B, CRP, CST3, CTSS, MMP 2, 9 and TIMP-1 increased after intervention. GC-MS analyses results indicated the presence of 21 compounds, of which 27% are poly unsaturated fatty acid (linoleic and palmetoleic acid) and 11.18% are phytosterols (stiotestrol). The observed effects of purslane seeds may be due to the presence of these compounds.</p><p>The findings suggest that glucose levels had decreased in all groups. However the decrease was more evident in the group consuming purslane seed and exercising simultaneously. Purslane seed consumption has been shown previously to impact glucose levels<xref ref-type="bibr" rid="b27">27</xref>. High levels of glucose in diabetes appears to be an initiating factor for the eventual cascade of biomarkers involved in inflammation and coronary heart diseases. Improvements in lipid profile were observed in the subjects after 16 weeks of aerobic training or purslane seed consumption or both (<xref ref-type="table" rid="t3">Table 3</xref>). The reduction of lipid profile in the aerobic group could be due to the decrease of free fatty acids, which negatively affect insulin resistance and excess lipid availability<xref ref-type="bibr" rid="b40">40</xref><xref ref-type="bibr" rid="b41">41</xref><xref ref-type="bibr" rid="b42">42</xref><xref ref-type="bibr" rid="b43">43</xref><xref ref-type="bibr" rid="b44">44</xref><xref ref-type="bibr" rid="b45">45</xref>. Hence, aerobic training is beneficial for patients with T2D<xref ref-type="bibr" rid="b40">40</xref><xref ref-type="bibr" rid="b42">42</xref><xref ref-type="bibr" rid="b46">46</xref>. The results obtained from our study also highlights the positive effects of purslane seed consumption on TG, LDL, cholesterol and HDL levels, which is consistent with earlier reports in T2D of Yemeni and Iranian patients<xref ref-type="bibr" rid="b5">5</xref><xref ref-type="bibr" rid="b31">31</xref>.</p><p>Levels of blood urea, uric acid and creatinine (<xref ref-type="table" rid="t3">Table 3</xref>) were reduced in all treated groups. In T2D overweight patients, uric acid and urea serve as biomarkers for impaired physical performances and are associated with blood glucose levels<xref ref-type="bibr" rid="b47">47</xref>. Purslane consumption in T2D mice<xref ref-type="bibr" rid="b48">48</xref> and T2D women has also been shown to reduce levels of creatinine, uric acid and urea<xref ref-type="bibr" rid="b49">49</xref>. Therefore, the reduction of blood nitrogen content seen in this study, may be lined to reduction in glucose levels (<xref ref-type="table" rid="t3">Table 3</xref>) following purslane seed consumption or aerobic training. In a study reported by Sousa<xref ref-type="bibr" rid="b50">50</xref>, twelve weeks of resistance training improved uric acid levels in T2D in Brazilian patients<xref ref-type="bibr" rid="b50">50</xref><xref ref-type="bibr" rid="b51">51</xref><xref ref-type="bibr" rid="b52">52</xref><xref ref-type="bibr" rid="b53">53</xref>. However, six months of aerobic training did not produce remarkable effects on creatinine and urea in untrained aged healthy women<xref ref-type="bibr" rid="b54">54</xref>.</p><p>The current study highlighted the beneficial effects of purslane seed consumption in alleviation of diabetes parameters. The beneficial effect may due to the presence of unsaturated fatty acids and beta-sistosterol as identified via GC-MS analysis (<xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="fig" rid="f2">Fig. 2</xref>). Previous reports have suggested that, unsaturated fatty acids are responsible in reducing levels of LDL and cholesterol synthesis<xref ref-type="bibr" rid="b55">55</xref>, enhancing insulin function<xref ref-type="bibr" rid="b56">56</xref> and improving glucose tolerance and lipid profile<xref ref-type="bibr" rid="b57">57</xref><xref ref-type="bibr" rid="b58">58</xref>. Another active substance in purslane seed is beta-sitosterol which is a phytosterol. Studies have found that beta-sitosterol has cholesterol<xref ref-type="bibr" rid="b59">59</xref> and LDL<xref ref-type="bibr" rid="b60">60</xref> lowering effects, increases the expression of VEGF (vascular endothelial growth factor) and FLK-1 (Fetal Liver Kinase 1) of VEGF receptors while modulating inflammation and regulation the immune systems. The effectiveness of purslane seed consumption is in lowering cholesterol levels explained by the synergistic effect of both phytosterols and unsaturated fatty acids<xref ref-type="bibr" rid="b61">61</xref>.</p><p>Hyperglycemia, hyperlipidemia, hyperinsulinemia<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b18">18</xref><xref ref-type="bibr" rid="b53">53</xref> and hyperuricemia<xref ref-type="bibr" rid="b62">62</xref><xref ref-type="bibr" rid="b63">63</xref><xref ref-type="bibr" rid="b64">64</xref> of diabetics are common symptoms which enhance production of pro inflammatory markers such as CRP, IL6, TNF&#x003b1;, NF-&#x003ba;B<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b18">18</xref><xref ref-type="bibr" rid="b53">53</xref><xref ref-type="bibr" rid="b62">62</xref><xref ref-type="bibr" rid="b64">64</xref>, reactive oxygen species (ROS) and reduce anti-inflammatory cytokine and adiponectin, which are involved in insulin resistance<xref ref-type="bibr" rid="b16">16</xref><xref ref-type="bibr" rid="b65">65</xref> and diabetes<xref ref-type="bibr" rid="b66">66</xref>. Reduction in the level of NF-&#x003ba;B and CRP in the inflammatory cascade was observed in treated groups of diabetics&#x02019; subjects. Our experiments showed that purslane seed consumption resulted in reduction of CRP and NF-&#x003ba;B (<xref ref-type="table" rid="t4">Table 4</xref> and <xref ref-type="fig" rid="f3">Fig. 3</xref>). This may be the result of inhibitory effects of unsaturated fatty acids on NF-&#x003ba;B reported in diabetic patients<xref ref-type="bibr" rid="b67">67</xref>. The inhibitory effect of unsaturated fatty acids such as omega 3 on CRP<xref ref-type="bibr" rid="b68">68</xref> in diabetic patients was reported even though the changes in CRP level were not significant. However, the significant reduction of CRP in the present study may indicate synergistic effect of various compounds found in purslane seed. Reduction in the level of CRP following resistance or strength training has been reported in patients with kidney disease<xref ref-type="bibr" rid="b45">45</xref><xref ref-type="bibr" rid="b69">69</xref>, older adults with T2D<xref ref-type="bibr" rid="b21">21</xref> and diabetic men<xref ref-type="bibr" rid="b70">70</xref> and in improving insulin sensitivity<xref ref-type="bibr" rid="b21">21</xref>. Various types of exercise may affect levels of NF&#x003ba;B differently. For instance, acute exercise did not change the level of NF&#x003ba;B in T2D patients<xref ref-type="bibr" rid="b53">53</xref>, but acute treadmill running raised the level of NF&#x003ba;B activity in rat skeletal muscles<xref ref-type="bibr" rid="b71">71</xref>. Therefore, reduction in levels of NF&#x003ba;B may be linked to CRP level reduction following aerobic exercise (<xref ref-type="table" rid="t4">Table 4</xref>) by impact on different synergistically pathways<xref ref-type="bibr" rid="b52">52</xref><xref ref-type="bibr" rid="b53">53</xref><xref ref-type="bibr" rid="b72">72</xref>. The expression of NF&#x003ba;B and CRP are interconnected whereby CRP enhances NF&#x003ba;B levels<xref ref-type="bibr" rid="b9">9</xref>, thus aerobic training and/or purslane seed consumption may directly or indirectly reduce the levels of NF&#x003ba;B via reducing the CRP.</p><p>The reduction of these two biomarkers is associated with the levels of inflammation and ROS in addition to regulation of ECM<xref ref-type="bibr" rid="b9">9</xref><xref ref-type="bibr" rid="b18">18</xref>. Matrix metalloproteinase (MMPs) and cathepsin S (CTSS) are proteases that degrade at least one component ECM and contribute for tissue remodeling and inflammation. Higher level of CRP and IL-6 are associated with higher level of CTSS<xref ref-type="bibr" rid="b17">17</xref> and higher levels of NF&#x003ba;B enhance MMPs level<xref ref-type="bibr" rid="b16">16</xref><xref ref-type="bibr" rid="b73">73</xref>. In pathological conditions such as diabetes, the balance between the protease enzymes (MMPs and CTSS) and their inhibitors (metallopeptidase inhibitor 1; TIMP-1 and CST3) are dysregulated<xref ref-type="bibr" rid="b74">74</xref>. The concentrations of MMP-2, 9 and TIMP-1 has been shown higher in T2D patients as compared to non-diabetic subjects<xref ref-type="bibr" rid="b75">75</xref><xref ref-type="bibr" rid="b76">76</xref> but in the current study, their levels were significantly reduced in all treated groups following different interventions (<xref ref-type="table" rid="t4">Table 4</xref> and <xref ref-type="fig" rid="f4">Fig. 4</xref>). Positive effects of exercise improve the balance between pro- and anti-inflammatory and oxidative stress markers which could improve nitric oxide bioavailability and alter MMPs and/or tissue inhibitors of MMPs (TIMP) activity. Chronic exercise training, that acts as a mechanical stressor for the arteries, could exert its effects by altering MMP/TIMPs activity directly and/or indirectly via the anti-inflammatory and oxidative stress responses of exercise<xref ref-type="bibr" rid="b77">77</xref>. The finding were concurrent with those of Kim <italic>et al</italic>.<xref ref-type="bibr" rid="b18">18</xref> which states that the level of MMP-2 was reduced after low intensity exercise training in diabetic mice<xref ref-type="bibr" rid="b78">78</xref>. The suppressive effect of purslane seed on MMP and TIMP activity may be caused by the presence of the unsaturated fatty acids in the seeds. Similar outcomes were observed in patients with multiple sclerosis<xref ref-type="bibr" rid="b79">79</xref> and in pregnant rats<xref ref-type="bibr" rid="b80">80</xref>.</p><p>CTSS is another important regulator of inflammation<xref ref-type="bibr" rid="b14">14</xref> that plays a role in pathological conditions such as diabetes<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b81">81</xref>. This regulator and its inhibitor CST3 are higher in diabetic patients as compared to healthy subjects<xref ref-type="bibr" rid="b82">82</xref>. Nonetheless the current interventions applied in this study reduced the protein and mRNA of both CTSS and CST3 (<xref ref-type="table" rid="t4">Table 4</xref> and <xref ref-type="fig" rid="f5">Fig. 5</xref>). This reduction following exercise may changes energy balance in adipose tissues<xref ref-type="bibr" rid="b83">83</xref>. Moreover, CTSS is positively correlated with weight loss<xref ref-type="bibr" rid="b83">83</xref><xref ref-type="bibr" rid="b84">84</xref> and TG level in obese subjects<xref ref-type="bibr" rid="b85">85</xref>. Reduction in CTSS and LDL was also observed in diet induced weight loss in non-obese men and women<xref ref-type="bibr" rid="b86">86</xref>. This further supports the hypothesis that CTSS contributes to cardiovascular risks in obesity<xref ref-type="bibr" rid="b83">83</xref>. The reduction of CTSS and CST3 was also observed in the group consuming purslane seed alone which could be due to the presence of unsaturated fatty acids and beta-sistosterol found in the seeds. However, the mechanism of for their reduction is unknown.</p><p>This study also evaluated the effect of intervention on biomarkers for insulin and beta cell activity. The levels of GLP-1 and GLP-1R were measured. GLP-1 is an insulinotropic in T2D which improves insulin secretion via it&#x02019;s receptor and by stimulation of glucose dependent insulin secretion<xref ref-type="bibr" rid="b19">19</xref>. It also has protective effect against degradation of ECM<xref ref-type="bibr" rid="b20">20</xref> and inhibits apoptosis of beta cells<xref ref-type="bibr" rid="b87">87</xref>. In addition GLP-1 mimetics are potential drugs to treat T2D<xref ref-type="bibr" rid="b88">88</xref>. The present findings, showed improving effects of interventions on GLP-1 and its receptor levels (<xref ref-type="table" rid="t4">Table 4</xref> and <xref ref-type="fig" rid="f3">Fig. 3</xref>). This is possibly linked to effects of purslane and aerobic training on beta cells mediated by the AMPK activated pathway<xref ref-type="bibr" rid="b88">88</xref><xref ref-type="bibr" rid="b89">89</xref>. Exercise and physical activity induce the AMPK pathway and inhibit energy consuming pathways such as fatty acid and cholesterol synthesis and stimulate the ATP catabolic pathway<xref ref-type="bibr" rid="b90">90</xref>. Since AMPK signaling pathway is among the crucial pathways involved in inflammation, following activation of this pathway, inhibition of NF&#x003ba;B and its downstream signaling pathway occurs<xref ref-type="bibr" rid="b91">91</xref>.</p><p>Thus the reduction in the inflammatory state of diabetes may be an important factor leading to improved insulin sensitivity and better metabolic control<xref ref-type="bibr" rid="b21">21</xref>. Increased physical activity and weight loss are associated with lower CRP and reduction in concentration of other markers of inflammation<xref ref-type="bibr" rid="b33">33</xref><xref ref-type="bibr" rid="b92">92</xref>. Therefore, both intervention alone or in combination might act through AMPK pathway and inhibit the activation of downstream inflammation through inhibition of CRP and NF&#x003ba;B. Among different insulin signaling pathways, available treatments for diabetes usually trigger the AMPK pathway which is insulin independent<xref ref-type="bibr" rid="b93">93</xref> and metformin activated that results in the inhibition of NF-kB activity in endothelial cells<xref ref-type="bibr" rid="b94">94</xref><xref ref-type="bibr" rid="b95">95</xref>. In this study, the level of NF-kB as a master inflammation key was reduced with purslane intake and/or aerobic training which could be due to activation of the AMPK pathway. Previous reports have indicated that aerobic exercise<xref ref-type="bibr" rid="b52">52</xref><xref ref-type="bibr" rid="b53">53</xref> and the uptake of unsaturated fatty acids activate the AMP and AMPK pathways<xref ref-type="bibr" rid="b96">96</xref>.</p></sec><sec disp-level="1"><title>Conclusion</title><p>The data obtained from this study indicated that 16 weeks of aerobic training or/and purslane seed consumption ere effective in regulation of diabetic parameters and biomarkers associated with atherosclerosis in women with T2D. This may be due to the synergistic effect of aerobic training and unsaturated fatty acids found in purslane seed which activate the AMP and AMPK pathways. This may result in the regulation of biomarkers involved in cardiovascular complications of T2D. The parallel effects of purslane intake and aerobic training in their simultaneous role were more prominent which could be a strong therapeutic effective factor on diabetic patients with CVD. Thus, with the benefits of this combination on reducing health risk factors, diabetic patients are advised to exploit this arrangement of alternative to control and manage their disease. However, further investigations are warranted, and such research should focus on identifying the specific properties of purslane seed, proper dose, role of various active compounds, as well as the possibilities for synergistic interactions not only between the various components of this seed, but also between various alternatives in treating and reducing symptoms of these diseases.</p></sec><sec disp-level="1"><title>Additional Information</title><p><bold>How to cite this article</bold>: Dehghan, F. <italic>et al</italic>. Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D). <italic>Sci. Rep.</italic>
<bold>6</bold>, 37819; doi: 10.1038/srep37819 (2016).</p><p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec><sec sec-type="supplementary-material" id="S1"><title>Supplementary Material</title><supplementary-material id="d33e24" content-type="local-data"><caption><title>Supplementary Information</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-s1.docx"/></supplementary-material></sec></body><back><ack><p>The authors wish to sincerely thank University of Malaya for High Impact Research grant UM.C/HIR/MOHE/MED/11 and research grant BKP065-2015 for supporting this research.</p></ack><ref-list><ref id="b1"><mixed-citation publication-type="journal"><name><surname>Shamima</surname><given-names>A.</given-names></name>, <name><surname>Rahman</surname><given-names>M.</given-names></name>, <name><surname>Krull</surname><given-names>S. A.</given-names></name> &#x00026; <name><surname>Sultana</surname><given-names>P.</given-names></name>
<article-title>Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey</article-title>. <source>Bulletin of the World Health Organization</source>
<volume>92</volume>, <fpage>204</fpage>&#x02013;<lpage>213A</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24700980</pub-id></mixed-citation></ref><ref id="b2"><mixed-citation publication-type="journal"><name><surname>Fadini</surname><given-names>G. P.</given-names></name>, <name><surname>Iori</surname><given-names>E.</given-names></name>, <name><surname>Marescotti</surname><given-names>M. C.</given-names></name>, <name><surname>de Kreutzenberg</surname><given-names>S. V.</given-names></name> &#x00026; <name><surname>Avogaro</surname><given-names>A.</given-names></name>
<article-title>Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients</article-title>. <source>Atherosclerosis</source>
<volume>235</volume>, <fpage>415</fpage>&#x02013;<lpage>417</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24933032</pub-id></mixed-citation></ref><ref id="b3"><mixed-citation publication-type="journal"><name><surname>Pati&#x000f1;o</surname><given-names>M. N.</given-names></name>
<etal/>. <article-title>Caries, periodontal disease and tooth loss in patients with diabetes mellitus types 1 and 2</article-title>. <source>Acta odontologica latinoamericana: AOL</source>
<volume>21</volume>, <fpage>127</fpage>&#x02013;<lpage>133</lpage> (<year>2007</year>).</mixed-citation></ref><ref id="b4"><mixed-citation publication-type="journal"><name><surname>Perez-Gallardo</surname><given-names>R. V.</given-names></name>
<etal/>. <article-title>Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats</article-title>. <source>J Bioenerg Biomembr</source>
<volume>46</volume>, <fpage>511</fpage>&#x02013;<lpage>518</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25425473</pub-id></mixed-citation></ref><ref id="b5"><mixed-citation publication-type="journal"><name><surname>El-Sayed</surname><given-names>M. I.</given-names></name>
<article-title>Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy</article-title>. <source>J Ethnopharmacol</source>
<volume>137</volume>, <fpage>643</fpage>&#x02013;<lpage>651</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21718775</pub-id></mixed-citation></ref><ref id="b6"><mixed-citation publication-type="journal"><name><surname>Laakso</surname><given-names>M.</given-names></name>
<article-title>Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008</article-title>. <source>Diabetes Care</source>
<volume>33</volume>, <fpage>442</fpage>&#x02013;<lpage>449</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20103560</pub-id></mixed-citation></ref><ref id="b7"><mixed-citation publication-type="journal"><name><surname>Galkina</surname><given-names>E.</given-names></name> &#x00026; <name><surname>Ley</surname><given-names>K.</given-names></name>
<article-title>Immune and inflammatory mechanisms of atherosclerosis</article-title>. <source>Annual review of immunology</source>
<volume>27</volume>, <fpage>165</fpage> (<year>2009</year>).</mixed-citation></ref><ref id="b8"><mixed-citation publication-type="journal"><name><surname>Watala</surname><given-names>C.</given-names></name> &#x00026; <name><surname>Winocour</surname><given-names>P.</given-names></name>
<article-title>The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects</article-title>. <source>Clinical Chemistry and Laboratory Medicine</source>
<volume>30</volume>, <fpage>513</fpage>&#x02013;<lpage>520</lpage> (<year>1992</year>).</mixed-citation></ref><ref id="b9"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>J. W.</given-names></name>
<etal/>. <article-title>C-reactive protein induces NF-kappaB activation through intracellular calcium and ROS in human mesangial cells</article-title>. <source>Nephron Exp Nephrol</source>
<volume>101</volume>, <fpage>e165</fpage>&#x02013;<lpage>172</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16131811</pub-id></mixed-citation></ref><ref id="b10"><mixed-citation publication-type="journal"><name><surname>Jialal</surname><given-names>I.</given-names></name> &#x00026; <name><surname>Devaraj</surname><given-names>S.</given-names></name>
<article-title>The Role of C-Reactive Protein Activation of Nuclear Factor Kappa-B in the Pathogenesis of Unstable Angina*</article-title>. <source>Journal of the American College of Cardiology</source>
<volume>49</volume>, <fpage>195</fpage>&#x02013;<lpage>197</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17222730</pub-id></mixed-citation></ref><ref id="b11"><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Santani</surname><given-names>D.</given-names></name>
<article-title>Role of NF-kappa B in the pathogenesis of diabetes and its associated complications</article-title>. <source>Pharmacol Rep</source>
<volume>61</volume>, <fpage>595</fpage>&#x02013;<lpage>603</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19815941</pub-id></mixed-citation></ref><ref id="b12"><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>W.</given-names></name> &#x00026; <name><surname>Ergul</surname><given-names>A.</given-names></name>
<article-title>Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size</article-title>. <source>Cardiovasc Diabetol</source>
<volume>5</volume>, <fpage>3</fpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16503991</pub-id></mixed-citation></ref><ref id="b13"><mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>X. W.</given-names></name>
<etal/>. <article-title>Role for Cysteine Protease Cathepsins in Heart Disease: Focus on Biology and Mechanisms With Clinical Implication</article-title>. <source>Circulation</source>
<volume>125</volume>, <fpage>1551</fpage>&#x02013;<lpage>1562</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22451605</pub-id></mixed-citation></ref><ref id="b14"><mixed-citation publication-type="journal"><name><surname>Jobs</surname><given-names>E.</given-names></name>
<etal/>. <article-title>Serum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly men</article-title>. <source>Diabetes Care</source>
<volume>36</volume>, <fpage>163</fpage>&#x02013;<lpage>165</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">22923671</pub-id></mixed-citation></ref><ref id="b15"><mixed-citation publication-type="journal"><name><surname>Kowluru</surname><given-names>R. A.</given-names></name>, <name><surname>Zhong</surname><given-names>Q.</given-names></name> &#x00026; <name><surname>Santos</surname><given-names>J. M.</given-names></name>
<article-title>Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9</article-title>. <source>Expert Opin Investig Drugs</source>
<volume>21</volume>, <fpage>797</fpage>&#x02013;<lpage>805</lpage> (<year>2012</year>).</mixed-citation></ref><ref id="b16"><mixed-citation publication-type="journal"><name><surname>Lorenzo</surname><given-names>O.</given-names></name>
<etal/>. <article-title>Potential Role of Nuclear Factor &#x003ba;B in Diabetic Cardiomyopathy</article-title>. <source>Mediators of Inflammation</source>
<volume>2011</volume> (<year>2011</year>).</mixed-citation></ref><ref id="b17"><mixed-citation publication-type="journal"><name><surname>Jobs</surname><given-names>E.</given-names></name>
<etal/>. <article-title>Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>95</volume>, <fpage>4460</fpage>&#x02013;<lpage>4464</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20610597</pub-id></mixed-citation></ref><ref id="b18"><mixed-citation publication-type="journal"><name><surname>Green</surname><given-names>C. J.</given-names></name>, <name><surname>Pedersen</surname><given-names>M.</given-names></name>, <name><surname>Pedersen</surname><given-names>B. K.</given-names></name> &#x00026; <name><surname>Scheele</surname><given-names>C.</given-names></name>
<article-title>Elevated NF-&#x003ba;B Activation Is Conserved in Human Myocytes Cultured From Obese Type 2 Diabetic Patients and Attenuated by AMP-Activated Protein Kinase</article-title>. <source>Diabetes</source>
<volume>60</volume>, <fpage>2810</fpage>&#x02013;<lpage>2819</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21911750</pub-id></mixed-citation></ref><ref id="b19"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>W.</given-names></name> &#x00026; <name><surname>Egan</surname><given-names>J. M.</given-names></name>
<article-title>The role of incretins in glucose homeostasis and diabetes treatment</article-title>. <source>Pharmacol Rev</source>
<volume>60</volume>, <fpage>470</fpage>&#x02013;<lpage>512</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">19074620</pub-id></mixed-citation></ref><ref id="b20"><mixed-citation publication-type="journal"><name><surname>Tate</surname><given-names>M.</given-names></name>, <name><surname>Robinson</surname><given-names>E.</given-names></name>, <name><surname>McDermott</surname><given-names>B. J.</given-names></name> &#x00026; <name><surname>Grieve</surname><given-names>D. J.</given-names></name>
<article-title>Glucagon-like peptide-1 protects against cardiac dysfunction and extracellular matrix remodelling IN experimental diabetes</article-title>. <source>Heart</source>
<volume>98</volume>, <fpage>A1</fpage> (<year>2012</year>).</mixed-citation></ref><ref id="b21"><mixed-citation publication-type="journal"><name><surname>Brooks</surname><given-names>N.</given-names></name>
<etal/>. <article-title>Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes</article-title>. <source>Int J Med Sci</source>
<volume>4</volume>, <fpage>19</fpage>&#x02013;<lpage>27</lpage> (<year>2007</year>).</mixed-citation></ref><ref id="b22"><mixed-citation publication-type="journal"><name><surname>Dehghan</surname><given-names>F.</given-names></name>
<etal/>. <article-title>Saffron with resistance exercise improves diabetic parameters through the GLUT4/AMPK pathway <italic>in-vitro</italic> and <italic>in-vivo</italic></article-title>. <source>Sci Rep</source>
<volume>6</volume>, <fpage>25139</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27122001</pub-id></mixed-citation></ref><ref id="b23"><mixed-citation publication-type="journal"><name><surname>Ranjbari</surname><given-names>A.</given-names></name>
<etal/>. <article-title><italic>In vivo</italic> and <italic>in vitro</italic> evaluation of the effects of Urtica dioica and swimming activity on diabetic factors and pancreatic beta cells</article-title>. <source>BMC Complement Altern Med</source>
<volume>16</volume>, <fpage>101</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26980377</pub-id></mixed-citation></ref><ref id="b24"><mixed-citation publication-type="journal"><name><surname>Shanker</surname><given-names>N.</given-names></name> &#x00026; <name><surname>Debnath</surname><given-names>S.</given-names></name>
<article-title>Impact of dehydration of purslane on retention of bioactive molecules and antioxidant activity</article-title>. <source>J Food Sci Technol</source>
<volume>52</volume>, <fpage>6631</fpage>&#x02013;<lpage>6638</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26396410</pub-id></mixed-citation></ref><ref id="b25"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>L.</given-names></name>
<etal/>. <article-title>Fatty acids and beta-carotene in australian purslane (Portulaca oleracea) varieties</article-title>. <source>J Chromatogr A</source>
<volume>893</volume>, <fpage>207</fpage>&#x02013;<lpage>213</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">11043602</pub-id></mixed-citation></ref><ref id="b26"><mixed-citation publication-type="journal"><name><surname>Uddin</surname><given-names>M. K.</given-names></name>
<etal/>. <article-title>Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes</article-title>. <source>ScientificWorldJournal</source>
<volume>2014</volume>, <fpage>951019</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24683365</pub-id></mixed-citation></ref><ref id="b27"><mixed-citation publication-type="journal"><name><surname>Gong</surname><given-names>F.</given-names></name>
<etal/>. <article-title>Hypoglycemic effects of crude polysaccharide from Purslane</article-title>. <source>International Journal of Molecular Sciences</source>
<volume>10</volume>, <fpage>880</fpage>&#x02013;<lpage>888</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19399226</pub-id></mixed-citation></ref><ref id="b28"><mixed-citation publication-type="journal"><name><surname>Abdalla</surname><given-names>H. M.</given-names><suffix>Jr.</suffix></name>
<article-title>Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet</article-title>. <source>Malays J Nutr</source>
<volume>16</volume>, <fpage>419</fpage>&#x02013;<lpage>429</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">22691995</pub-id></mixed-citation></ref><ref id="b29"><mixed-citation publication-type="journal"><name><surname>Salehi</surname><given-names>A.</given-names></name> &#x00026; <name><surname>Farzanegi</surname><given-names>P.</given-names></name>
<article-title>Effect of 8 weeks of resistance training with and without portulacalo seeds on some of liver injury markers in women with diabetes type 2</article-title>. <source>URMIA MEDICAL JOURNAL</source>
<volume>25</volume>, <fpage>968</fpage>&#x02013;<lpage>978</lpage> (<year>2015</year>).</mixed-citation></ref><ref id="b30"><mixed-citation publication-type="journal"><name><surname>Fakoory Jouybari</surname><given-names>M.</given-names></name>, <name><surname>Farzanegi</surname><given-names>P.</given-names></name> &#x00026; <name><surname>A.</surname><given-names>B.</given-names></name>
<article-title>The effect of 8-week aerobic exercise with purslane supplementation consumption on peroxidant and antioxidants indicators in women with type 2 diabetes</article-title>. <source>J Shahid Sadoughi Univ Med Sci</source>
<volume>22</volume>, <fpage>928</fpage>&#x02013;<lpage>939</lpage> (<year>2014</year>).</mixed-citation></ref><ref id="b31"><mixed-citation publication-type="journal"><name><surname>Esmaillzadeh</surname><given-names>A.</given-names></name>, <name><surname>Zakizadeh</surname><given-names>E.</given-names></name>, <name><surname>Faghihimani</surname><given-names>E.</given-names></name>, <name><surname>Gohari</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Jazayeri</surname><given-names>S.</given-names></name>
<article-title>The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: A randomized controlled cross-over clinical trial</article-title>. <source>J Res Med Sci</source>
<volume>20</volume>, <fpage>47</fpage>&#x02013;<lpage>53</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25767522</pub-id></mixed-citation></ref><ref id="b32"><mixed-citation publication-type="journal"><name><surname>Ciolac</surname><given-names>E. G.</given-names></name> &#x00026; <name><surname>Physical</surname><given-names>G. G.</given-names></name>
<article-title>exercise and metabolic syndrome</article-title>. <source>Rev Bras Med Esporte</source>
<volume>10</volume>, <fpage>319</fpage>&#x02013;<lpage>324</lpage> (<year>2004</year>).</mixed-citation></ref><ref id="b33"><mixed-citation publication-type="journal"><name><surname>de Lemos</surname><given-names>E. T.</given-names></name>, <name><surname>Oliveira</surname><given-names>J.</given-names></name>, <name><surname>Pinheiro</surname><given-names>J. P.</given-names></name> &#x00026; <name><surname>Reis</surname><given-names>F.</given-names></name>
<article-title>Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus</article-title>. <source>Oxid Med Cell Longev</source>
<volume>2012</volume>, <fpage>741545</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22928086</pub-id></mixed-citation></ref><ref id="b34"><mixed-citation publication-type="journal"><name><surname>Raabo</surname><given-names>B. E.</given-names></name> &#x00026; <name><surname>Terkildsen</surname><given-names>T.</given-names></name>
<article-title>On the enzymatic determination of blood glucose</article-title>. <source>Scandinavian journal of clinical and laboratory investigation</source>
<volume>12</volume>, <fpage>402</fpage>&#x02013;<lpage>407</lpage> (<year>1960</year>).<pub-id pub-id-type="pmid">13738785</pub-id></mixed-citation></ref><ref id="b35"><mixed-citation publication-type="journal"><name><surname>Friedewald</surname><given-names>W. T.</given-names></name>, <name><surname>Levy</surname><given-names>R. I.</given-names></name> &#x00026; <name><surname>Fredrickson</surname><given-names>D. S.</given-names></name>
<article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>. <source>Clinical chemistry</source>
<volume>18</volume>, <fpage>499</fpage>&#x02013;<lpage>502</lpage> (<year>1972</year>).<pub-id pub-id-type="pmid">4337382</pub-id></mixed-citation></ref><ref id="b36"><mixed-citation publication-type="journal"><name><surname>Fossati</surname><given-names>P.</given-names></name> &#x00026; <name><surname>Prencipe</surname><given-names>L.</given-names></name>
<article-title>Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide</article-title>. <source>Clinical chemistry</source>
<volume>28</volume>, <fpage>2077</fpage>&#x02013;<lpage>2080</lpage> (<year>1982</year>).<pub-id pub-id-type="pmid">6812986</pub-id></mixed-citation></ref><ref id="b37"><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>M. L.</given-names></name> &#x00026; <name><surname>Medrano</surname><given-names>J. F.</given-names></name>
<article-title>Real-time PCR for mRNA quantitation</article-title>. <source>Biotechniques</source>
<volume>39</volume>, <fpage>75</fpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16060372</pub-id></mixed-citation></ref><ref id="b38"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>W.</given-names></name>, <name><surname>Zheng</surname><given-names>H.</given-names></name>, <name><surname>Bukuru</surname><given-names>J.</given-names></name> &#x00026; <name><surname>De Kimpe</surname><given-names>N.</given-names></name>
<article-title>Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus</article-title>. <source>Journal of Ethnopharmacology</source>
<volume>92</volume>, <fpage>1</fpage>&#x02013;<lpage>21</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15099842</pub-id></mixed-citation></ref><ref id="b39"><mixed-citation publication-type="journal"><name><surname>Ivorra</surname><given-names>M.</given-names></name>, <name><surname>Paya</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Villar</surname><given-names>A.</given-names></name>
<article-title>A review of natural products and plants as potential antidiabetic drugs</article-title>. <source>Journal of Ethnopharmacology</source>
<volume>27</volume>, <fpage>243</fpage>&#x02013;<lpage>275</lpage> (<year>1989</year>).<pub-id pub-id-type="pmid">2693840</pub-id></mixed-citation></ref><ref id="b40"><mixed-citation publication-type="journal"><name><surname>Chien</surname><given-names>K.-L.</given-names></name>, <name><surname>Chen</surname><given-names>M.-F.</given-names></name>, <name><surname>Hsu</surname><given-names>H.-C.</given-names></name>, <name><surname>Su</surname><given-names>T.-C.</given-names></name> &#x00026; <name><surname>Lee</surname><given-names>Y.-T.</given-names></name>
<article-title>Sports activity and risk of type 2 diabetes in Chinese</article-title>. <source>Diabetes Research and Clinical Practice</source>
<volume>84</volume>, <fpage>311</fpage>&#x02013;<lpage>318</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19359062</pub-id></mixed-citation></ref><ref id="b41"><mixed-citation publication-type="journal"><name><surname>Gordon</surname><given-names>L. A.</given-names></name>
<etal/>. <article-title>Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes</article-title>. <source>BMC Complement Altern Med</source>
<volume>8</volume>, <fpage>21</fpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18477407</pub-id></mixed-citation></ref><ref id="b42"><mixed-citation publication-type="journal"><name><surname>Hayashino</surname><given-names>Y.</given-names></name>, <name><surname>Jackson</surname><given-names>J. L.</given-names></name>, <name><surname>Fukumori</surname><given-names>N.</given-names></name>, <name><surname>Nakamura</surname><given-names>F.</given-names></name> &#x00026; <name><surname>Fukuhara</surname><given-names>S.</given-names></name>
<article-title>Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials</article-title>. <source>Diabetes Research and Clinical Practice</source>
<volume>98</volume>, <fpage>349</fpage>&#x02013;<lpage>360</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23116535</pub-id></mixed-citation></ref><ref id="b43"><mixed-citation publication-type="journal"><name><surname>Miyatake</surname><given-names>N.</given-names></name>
<etal/>. <article-title>Daily walking reduces visceral adipose tissue areas and improves insulin resistance in Japanese obese subjects</article-title>. <source>Diabetes Res Clin Pract</source>
<volume>58</volume>, <fpage>101</fpage>&#x02013;<lpage>107</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12213351</pub-id></mixed-citation></ref><ref id="b44"><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>R.</given-names></name>
<etal/>. <article-title>Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial</article-title>. <source>Ann Intern Med</source>
<volume>133</volume>, <fpage>92</fpage>&#x02013;<lpage>103</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10896648</pub-id></mixed-citation></ref><ref id="b45"><mixed-citation publication-type="journal"><name><surname>Saremi</surname><given-names>A.</given-names></name>, <name><surname>Mosleh abadi</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Parastesh</surname><given-names>M.</given-names></name>
<article-title>ffects of Twelve-week Strength Training on Serum Chemerin, TNF-&#x003b1; and CRP Level in Subjects with the Metabolic Syndrome</article-title>. <source>Iranian Journal of Endocrinology and Metabolism</source>
<volume>12</volume>, <fpage>536</fpage>&#x02013;<lpage>543</lpage> (<year>2011</year>).</mixed-citation></ref><ref id="b46"><mixed-citation publication-type="journal"><name><surname>Davey Smith</surname><given-names>G.</given-names></name>
<etal/>. <article-title>Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial</article-title>. <source>Ann Intern Med</source>
<volume>142</volume>, <fpage>313</fpage>&#x02013;<lpage>322</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15738450</pub-id></mixed-citation></ref><ref id="b47"><mixed-citation publication-type="journal"><name><surname>Bo</surname><given-names>S.</given-names></name>, <name><surname>Cavallo-Perin</surname><given-names>P.</given-names></name>, <name><surname>Gentile</surname><given-names>L.</given-names></name>, <name><surname>Repetti</surname><given-names>E.</given-names></name> &#x00026; <name><surname>Pagano</surname><given-names>G.</given-names></name>
<article-title>Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes</article-title>. <source>Eur J Clin Invest</source>
<volume>31</volume>, <fpage>318</fpage>&#x02013;<lpage>321</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11298778</pub-id></mixed-citation></ref><ref id="b48"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>A. S.</given-names></name>
<etal/>. <article-title>An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice</article-title>. <source>Am J Chin Med</source>
<volume>40</volume>, <fpage>495</fpage>&#x02013;<lpage>510</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22745066</pub-id></mixed-citation></ref><ref id="b49"><mixed-citation publication-type="journal"><name><surname>Farzanegi</surname><given-names>P.</given-names></name>, <name><surname>Pour Amin</surname><given-names>Z.</given-names></name> &#x00026; <name><surname>Habibian</surname><given-names>M.</given-names></name>
<article-title>Changes of Liver Trans-Aminases after a Period of Selected Aerobic Training in Postmenopausal Women</article-title>. <source>Medical Labrotoary Journal</source>
<volume>8</volume>, <fpage>22</fpage>&#x02013;<lpage>28</lpage> (<year>2014</year>).</mixed-citation></ref><ref id="b50"><mixed-citation publication-type="journal"><name><surname>Sousa</surname><given-names>M. S.</given-names></name>
<etal/>. <article-title>Resistance Training in Type 2 Diabetic Patients Improves Uric Acid levels</article-title>. <source>J Hum Kinet</source>
<volume>43</volume>, <fpage>17</fpage>&#x02013;<lpage>24</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25713640</pub-id></mixed-citation></ref><ref id="b51"><mixed-citation publication-type="journal"><name><surname>Bodine</surname><given-names>S. C.</given-names></name>
<article-title>mTOR signaling and the molecular adaptation to resistance exercise</article-title>. <source>Med Sci Sports Exerc</source>
<volume>38</volume>, <fpage>1950</fpage>&#x02013;<lpage>1957</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">17095929</pub-id></mixed-citation></ref><ref id="b52"><mixed-citation publication-type="journal"><name><surname>Sriwijitkamol</surname><given-names>A.</given-names></name>
<etal/>. <article-title>Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training</article-title>. <source>Diabetes</source>
<volume>55</volume>, <fpage>760</fpage>&#x02013;<lpage>767</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16505240</pub-id></mixed-citation></ref><ref id="b53"><mixed-citation publication-type="journal"><name><surname>Tantiwong</surname><given-names>P.</given-names></name>
<etal/>. <article-title>NF-kappaB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>299</volume>, <fpage>E794</fpage>&#x02013;<lpage>801</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20739506</pub-id></mixed-citation></ref><ref id="b54"><mixed-citation publication-type="journal"><name><surname>Bijeh</surname><given-names>N.</given-names></name> &#x00026; <name><surname>Farahati</surname><given-names>S.</given-names></name>
<article-title>The Effect of Six Months of Aerobic training on Renal Function Markers in Untrained Middle-Aged Women</article-title>. <source>Int J Sports Studies</source>
<volume>3</volume>, <fpage>218</fpage>&#x02013;<lpage>224</lpage> (<year>2013</year>).</mixed-citation></ref><ref id="b55"><mixed-citation publication-type="journal"><name><surname>Nestel</surname><given-names>P. J.</given-names></name>
<article-title>Fish oil and cardiovascular disease: lipids and arterial function</article-title>. <source>The American Journal of Clinical Nutrition</source>
<volume>71</volume>, <fpage>228S</fpage>&#x02013;<lpage>231S</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10617976</pub-id></mixed-citation></ref><ref id="b56"><mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>J. Y.</given-names></name>
<article-title>Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes</article-title>. <source>Korean Diabetes J</source>
<volume>34</volume>, <fpage>84</fpage>&#x02013;<lpage>85</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20548839</pub-id></mixed-citation></ref><ref id="b57"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>J.</given-names></name>
<etal/>. <article-title>Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome</article-title>. <source>British Journal of Nutrition</source>
<volume>105</volume>, <fpage>1572</fpage>&#x02013;<lpage>1582</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21276281</pub-id></mixed-citation></ref><ref id="b58"><mixed-citation publication-type="journal"><name><surname>Samimi</surname><given-names>M.</given-names></name>, <name><surname>Jamilian</surname><given-names>M.</given-names></name>, <name><surname>Asemi</surname><given-names>Z.</given-names></name> &#x00026; <name><surname>Esmaillzadeh</surname><given-names>A.</given-names></name>
<article-title>Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial</article-title>. <source>Clin Nutr</source>
<volume>34</volume>, <fpage>388</fpage>&#x02013;<lpage>393</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">24973862</pub-id></mixed-citation></ref><ref id="b59"><mixed-citation publication-type="journal"><name><surname>Ostlund</surname><given-names>R. E.</given-names><suffix>Jr.</suffix></name>
<article-title>Phytosterols and cholesterol metabolism</article-title>. <source>Curr Opin Lipidol</source>
<volume>15</volume>, <fpage>37</fpage>&#x02013;<lpage>41</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15166807</pub-id></mixed-citation></ref><ref id="b60"><mixed-citation publication-type="journal"><name><surname>Abumweis</surname><given-names>S. S.</given-names></name>, <name><surname>Barake</surname><given-names>R.</given-names></name> &#x00026; <name><surname>Jones</surname><given-names>P. J.</given-names></name>
<article-title>Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials</article-title>. <source>Food Nutr Res</source>
<volume>52</volume> (<year>2008</year>).</mixed-citation></ref><ref id="b61"><mixed-citation publication-type="journal"><name><surname>Micallef</surname><given-names>M. A.</given-names></name> &#x00026; <name><surname>Garg</surname><given-names>M. L.</given-names></name>
<article-title>The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women</article-title>. <source>J Nutr</source>
<volume>138</volume>, <fpage>1086</fpage>&#x02013;<lpage>1090</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18492838</pub-id></mixed-citation></ref><ref id="b62"><mixed-citation publication-type="journal"><name><surname>Lyngdoh</surname><given-names>T.</given-names></name>
<etal/>. <article-title>Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study</article-title>. <source>PLoS One</source>
<volume>6</volume>, <fpage>e19901</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21625475</pub-id></mixed-citation></ref><ref id="b63"><mixed-citation publication-type="journal"><name><surname>Netea</surname><given-names>M. G.</given-names></name>, <name><surname>Kullberg</surname><given-names>B. J.</given-names></name>, <name><surname>Blok</surname><given-names>W. L.</given-names></name>, <name><surname>Netea</surname><given-names>R. T.</given-names></name> &#x00026; <name><surname>van der Meer</surname><given-names>J. W.</given-names></name>
<article-title>The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice</article-title>. <source>Blood</source>
<volume>89</volume>, <fpage>577</fpage>&#x02013;<lpage>582</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9002961</pub-id></mixed-citation></ref><ref id="b64"><mixed-citation publication-type="journal"><name><surname>Zapolski</surname><given-names>T.</given-names></name>
<etal/>. <article-title>Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease</article-title>. <source>Kardiol Pol</source>
<volume>69</volume>, <fpage>319</fpage>&#x02013;<lpage>326</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21523662</pub-id></mixed-citation></ref><ref id="b65"><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>B. M.</given-names></name> &#x00026; <name><surname>Li</surname><given-names>C.</given-names></name>
<article-title>Diabetes and hypertension: is there a common metabolic pathway?</article-title>
<source>Curr Atheroscler Rep</source>
<volume>14</volume>, <fpage>160</fpage>&#x02013;<lpage>166</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22281657</pub-id></mixed-citation></ref><ref id="b66"><mixed-citation publication-type="journal"><name><surname>Golbidi</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Laher</surname><given-names>I.</given-names></name>
<article-title>Exercise Induced Adipokine Changes and the Metabolic Syndrome</article-title>. <source>Journal of Diabetes Research</source>
<volume>2014</volume>, <fpage>16</fpage> (<year>2014</year>).</mixed-citation></ref><ref id="b67"><mixed-citation publication-type="journal"><name><surname>Bellenger</surname><given-names>J.</given-names></name>
<etal/>. <article-title>High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition</article-title>. <source>Diabetes</source>
<volume>60</volume>, <fpage>1090</fpage>&#x02013;<lpage>1099</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21330635</pub-id></mixed-citation></ref><ref id="b68"><mixed-citation publication-type="journal"><name><surname>Malekshahi Moghadam</surname><given-names>A.</given-names></name>
<etal/>. <article-title>Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients</article-title>. <source>Singapore Med J</source>
<volume>53</volume>, <fpage>615</fpage>&#x02013;<lpage>619</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23023905</pub-id></mixed-citation></ref><ref id="b69"><mixed-citation publication-type="journal"><name><surname>Castaneda</surname><given-names>C.</given-names></name>
<etal/>. <article-title>Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease</article-title>. <source>Am J Kidney Dis</source>
<volume>43</volume>, <fpage>607</fpage>&#x02013;<lpage>616</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15042537</pub-id></mixed-citation></ref><ref id="b70"><mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>C. K.</given-names></name>, <name><surname>Won</surname><given-names>D.</given-names></name>, <name><surname>Pruthi</surname><given-names>S.</given-names></name>, <name><surname>Lin</surname><given-names>S. S.</given-names></name> &#x00026; <name><surname>Barnard</surname><given-names>R. J.</given-names></name>
<article-title>Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men</article-title>. <source>Diabetes Res Clin Pract</source>
<volume>73</volume>, <fpage>249</fpage>&#x02013;<lpage>259</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16616795</pub-id></mixed-citation></ref><ref id="b71"><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>R. C.</given-names></name>
<etal/>. <article-title>Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle</article-title>. <source>Am J Physiol Cell Physiol</source>
<volume>289</volume>, <fpage>C794</fpage>&#x02013;<lpage>801</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15888549</pub-id></mixed-citation></ref><ref id="b72"><mixed-citation publication-type="journal"><name><surname>Durham</surname><given-names>W. J.</given-names></name>
<etal/>. <article-title>Fatiguing exercise reduces DNA binding activity of NF-kappaB in skeletal muscle nuclei</article-title>. <source>J Appl Physiol (1985)</source>
<volume>97</volume>, <fpage>1740</fpage>&#x02013;<lpage>1745</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15208298</pub-id></mixed-citation></ref><ref id="b73"><mixed-citation publication-type="journal"><name><surname>Newby</surname><given-names>A. C.</given-names></name>
<article-title>Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability</article-title>. <source>Arterioscler Thromb Vasc Biol</source>
<volume>28</volume>, <fpage>2108</fpage>&#x02013;<lpage>2114</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18772495</pub-id></mixed-citation></ref><ref id="b74"><mixed-citation publication-type="journal"><name><surname>Lewandowski</surname><given-names>K. C.</given-names></name>, <name><surname>Banach</surname><given-names>E.</given-names></name>, <name><surname>Bienkiewicz</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Lewinski</surname><given-names>A.</given-names></name>
<article-title>Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia</article-title>. <source>Arch Med Sci</source>
<volume>7</volume>, <fpage>294</fpage>&#x02013;<lpage>303</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">22291770</pub-id></mixed-citation></ref><ref id="b75"><mixed-citation publication-type="journal"><name><surname>Derosa</surname><given-names>G.</given-names></name>
<etal/>. <article-title>Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects</article-title>. <source>Diabetes Metab</source>
<volume>33</volume>, <fpage>129</fpage>&#x02013;<lpage>134</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17320450</pub-id></mixed-citation></ref><ref id="b76"><mixed-citation publication-type="journal"><name><surname>Signorelli</surname><given-names>S. S.</given-names></name>
<etal/>. <article-title>Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease</article-title>. <source>Vasc Med</source>
<volume>10</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15920993</pub-id></mixed-citation></ref><ref id="b77"><mixed-citation publication-type="journal"><name><surname>Donley</surname><given-names>D. A.</given-names></name>
<etal/>. <article-title>Aerobic exercise training reduces arterial stiffness in metabolic syndrome</article-title>. <source>J Appl Physiol (1985)</source>
<volume>116</volume>, <fpage>1396</fpage>&#x02013;<lpage>1404</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24744384</pub-id></mixed-citation></ref><ref id="b78"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J. S.</given-names></name>
<etal/>. <article-title>Effect of exercise training of different intensities on anti-inflammatory reaction in streptozotocin-induced diabetic rats</article-title>. <source>Biol Sport</source>
<volume>31</volume>, <fpage>73</fpage>&#x02013;<lpage>79</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25187675</pub-id></mixed-citation></ref><ref id="b79"><mixed-citation publication-type="journal"><name><surname>Shinto</surname><given-names>L.</given-names></name>, <name><surname>Marracci</surname><given-names>G.</given-names></name>, <name><surname>Bumgarner</surname><given-names>L.</given-names></name> &#x00026; <name><surname>Yadav</surname><given-names>V.</given-names></name>
<article-title>The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis</article-title>. <source>Autoimmune Diseases</source>
<volume>2011</volume> (<year>2011</year>).</mixed-citation></ref><ref id="b80"><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>M. A.</given-names></name>
<etal/>. <article-title>Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source>
<volume>65</volume>, <fpage>23</fpage>&#x02013;<lpage>29</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11487304</pub-id></mixed-citation></ref><ref id="b81"><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>S.</given-names></name>, <name><surname>Singh</surname><given-names>R. K.</given-names></name>, <name><surname>Dastidar</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Ray</surname><given-names>A.</given-names></name>
<article-title>Cysteine cathepsin S as an immunomodulatory target: present and future trends</article-title>. <source>Expert Opin Ther Targets</source>
<volume>12</volume>, <fpage>291</fpage>&#x02013;<lpage>299</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18269339</pub-id></mixed-citation></ref><ref id="b82"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J.</given-names></name>
<etal/>. <article-title>Increased serum cathepsin S in patients with atherosclerosis and diabetes</article-title>. <source>Atherosclerosis</source>
<volume>186</volume>, <fpage>411</fpage>&#x02013;<lpage>419</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16140306</pub-id></mixed-citation></ref><ref id="b83"><mixed-citation publication-type="journal"><name><surname>Naour</surname><given-names>N.</given-names></name>
<etal/>. <article-title>Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>95</volume>, <fpage>1861</fpage>&#x02013;<lpage>1868</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20164293</pub-id></mixed-citation></ref><ref id="b84"><mixed-citation publication-type="journal"><name><surname>Taleb</surname><given-names>S.</given-names></name>
<etal/>. <article-title>Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>91</volume>, <fpage>1042</fpage>&#x02013;<lpage>1047</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16394095</pub-id></mixed-citation></ref><ref id="b85"><mixed-citation publication-type="journal"><name><surname>Taleb</surname><given-names>S.</given-names></name>
<etal/>. <article-title>Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis</article-title>. <source>FASEB J</source>
<volume>19</volume>, <fpage>1540</fpage>&#x02013;<lpage>1542</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15985526</pub-id></mixed-citation></ref><ref id="b86"><mixed-citation publication-type="journal"><name><surname>Jobs</surname><given-names>E.</given-names></name>
<etal/>. <article-title>Influence of a prudent diet on circulating cathepsin S in humans</article-title>. <source>Nutr J</source>
<volume>13</volume>, <fpage>84</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25128296</pub-id></mixed-citation></ref><ref id="b87"><mixed-citation publication-type="journal"><name><surname>Farilla</surname><given-names>L.</given-names></name>
<etal/>. <article-title>Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats</article-title>. <source>Endocrinology</source>
<volume>143</volume>, <fpage>4397</fpage>&#x02013;<lpage>4408</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12399437</pub-id></mixed-citation></ref><ref id="b88"><mixed-citation publication-type="journal"><name><surname>Coughlan</surname><given-names>K. A.</given-names></name>, <name><surname>Valentine</surname><given-names>R. J.</given-names></name>, <name><surname>Ruderman</surname><given-names>N. B.</given-names></name> &#x00026; <name><surname>Saha</surname><given-names>A. K.</given-names></name>
<article-title>AMPK activation: a therapeutic target for type 2 diabetes?</article-title>
<source>Diabetes Metab Syndr Obes</source>
<volume>7</volume>, <fpage>241</fpage>&#x02013;<lpage>253</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25018645</pub-id></mixed-citation></ref><ref id="b89"><mixed-citation publication-type="journal"><name><surname>Svegliati-Baroni</surname><given-names>G.</given-names></name>
<etal/>. <article-title>Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis</article-title>. <source>Liver Int</source>
<volume>31</volume>, <fpage>1285</fpage>&#x02013;<lpage>1297</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21745271</pub-id></mixed-citation></ref><ref id="b90"><mixed-citation publication-type="journal"><name><surname>Viollet</surname><given-names>B.</given-names></name>
<etal/>. <article-title>Targeting the AMPK pathway for the treatment of Type 2 diabetes</article-title>. <source>Front Biosci (Landmark Ed)</source>
<volume>14</volume>, <fpage>3380</fpage>&#x02013;<lpage>3400</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19273282</pub-id></mixed-citation></ref><ref id="b91"><mixed-citation publication-type="journal"><name><surname>Salminen</surname><given-names>A.</given-names></name>, <name><surname>Hyttinen</surname><given-names>J. M.</given-names></name> &#x00026; <name><surname>Kaarniranta</surname><given-names>K.</given-names></name>
<article-title>AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan</article-title>. <source>J Mol Med (Berl)</source>
<volume>89</volume>, <fpage>667</fpage>&#x02013;<lpage>676</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21431325</pub-id></mixed-citation></ref><ref id="b92"><mixed-citation publication-type="journal"><name><surname>Flynn</surname><given-names>M. G.</given-names></name>, <name><surname>McFarlin</surname><given-names>B. K.</given-names></name> &#x00026; <name><surname>Markofski</surname><given-names>M. M.</given-names></name>
<article-title>The Anti-Inflammatory Actions of Exercise Training</article-title>. <source>Am J Lifestyle Med</source>
<volume>1</volume>, <fpage>220</fpage>&#x02013;<lpage>235</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">25431545</pub-id></mixed-citation></ref><ref id="b93"><mixed-citation publication-type="journal"><name><surname>Schultze</surname><given-names>S. M.</given-names></name>, <name><surname>Hemmings</surname><given-names>B. A.</given-names></name>, <name><surname>Niessen</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Tschopp</surname><given-names>O.</given-names></name>
<article-title>PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis</article-title>. <source>Expert Rev Mol Med</source>
<volume>14</volume>, <fpage>e1</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22233681</pub-id></mixed-citation></ref><ref id="b94"><mixed-citation publication-type="journal"><name><surname>Katerelos</surname><given-names>M.</given-names></name>
<etal/>. <article-title>5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-kappaB</article-title>. <source>Immunol Cell Biol</source>
<volume>88</volume>, <fpage>754</fpage>&#x02013;<lpage>760</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20404837</pub-id></mixed-citation></ref><ref id="b95"><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>N. L.</given-names></name>
<etal/>. <article-title>Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation</article-title>. <source>Int J Cardiol</source>
<volume>134</volume>, <fpage>169</fpage>&#x02013;<lpage>175</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">18597869</pub-id></mixed-citation></ref><ref id="b96"><mixed-citation publication-type="journal"><name><surname>Higuchi</surname><given-names>T.</given-names></name>, <name><surname>Shirai</surname><given-names>N.</given-names></name>, <name><surname>Saito</surname><given-names>M.</given-names></name>, <name><surname>Suzuki</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Kagawa</surname><given-names>Y.</given-names></name>
<article-title>Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids</article-title>. <source>The Journal of Nutritional Biochemistry</source>
<volume>19</volume>, <fpage>577</fpage>&#x02013;<lpage>586</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">17911005</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p><bold>Author Contributions</bold> Conceived and designed the study: F.D., K.G., MA.A., and A.Y. Performed the experiments: F.D., S.H. Analyzed the data: F.D., M.A and MA.A. Contributed reagents/materials/analysis tools: F.D., A.Y., MA.A., P.F., and S.M. Wrote the manuscript: F.D., R.S., K.G., M.A., A.Y., and MA.A.</p></fn></fn-group></back><floats-group><fig id="f1"><label>Figure 1</label><caption><title>Schematic illustration of some of the key pathological pathways that are involved in both type 2 diabetes and atherosclerosis.</title><p>Hyperglycemia, hyperlipidemia, hyperinsulinia, and hyperuricimia increase ROS generation through oxidative stress. ROS activates a number of stress sensitive kinase which mediates insulin resistance via activation of NF-&#x003ba;B and CRP. On the other hand, activation of NF-&#x003ba;B and CRP affect the structure of extracellular matrix and increase the activity of MMP and cathepsin S which are involved in atherosclerosis and diabetes. Exercise and purslane intake improve the regulation of biomarkers involved in the activation of these pathways. TG; triglycerides, LDL; Low-density lipoprotein, ROS; reactive oxygen species, NF-&#x003ba;B; nuclear factor kappa-light-chain-enhancer of activated B cells, CRP; C-reactive protein, MMPs; Matrix metalloproteinase, TIMP-1; metallopeptidase inhibitor 1.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-f1"/></fig><fig id="f2"><label>Figure 2</label><caption><title>Chromatographic profile of purslane seed methanolic extract, the 21 known and unknown peaks components are identified.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-f2"/></fig><fig id="f3"><label>Figure 3</label><caption><title>Blood CRP, NF-&#x003ba;B, GPL-1, and GPL1-R, mRNA expression and activity at pre or post treatment in diabetic type 2 women. Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM.</title><p>PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p&#x02009;&#x0003c;&#x02009;0.05 as compared to Placebo group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-f3"/></fig><fig id="f4"><label>Figure 4</label><caption><title>Blood MMP-2, MMP-9, and TMP-1 mRNA expression and activity at pre or post treatment in diabetic type 2 women. Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM.</title><p>PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p&#x02009;&#x0003c;&#x02009;0.05 as compared to Placebo group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-f4"/></fig><fig id="f5"><label>Figure 5</label><caption><title>Blood CST3 and CTSS mRNA expression and activity at pre or post treatment in diabetic type 2 women.</title><p>Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p&#x02009;&#x0003c;&#x02009;0.05 as compared to Placebo group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep37819-f5"/></fig><table-wrap position="float" id="t1"><label>Table 1</label><caption><title>Characteristics and demographics of the diabetics&#x02019; subjects.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">Placebo (PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training&#x02009;+&#x02009;Placebo (AT&#x02009;+&#x02009;PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Purslane Seeds (PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training&#x02009;+&#x02009;Purslane Seeds (AT&#x02009;+&#x02009;PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Age, year</td><td align="center" valign="top" charoff="50">50.17&#x02009;&#x000b1;&#x02009;5.34</td><td align="center" valign="top" charoff="50">58.83&#x02009;&#x000b1;&#x02009;6.79</td><td align="center" valign="top" charoff="50">52.33&#x02009;&#x000b1;&#x02009;4.08</td><td align="center" valign="top" charoff="50">61.17&#x02009;&#x000b1;&#x02009;4.88</td></tr><tr><td align="left" valign="top" charoff="50">Height, cm</td><td align="center" valign="top" charoff="50">160.67&#x02009;&#x000b1;&#x02009;6.44</td><td align="center" valign="top" charoff="50">162.50&#x02009;&#x000b1;&#x02009;6.53</td><td align="center" valign="top" charoff="50">159.17&#x02009;&#x000b1;&#x02009;6.65</td><td align="center" valign="top" charoff="50">154.50&#x02009;&#x000b1;&#x02009;10.60</td></tr><tr><td align="left" valign="top" charoff="50">Weight, cm</td><td align="center" valign="top" charoff="50">75.67&#x02009;&#x000b1;&#x02009;9.44</td><td align="center" valign="top" charoff="50">79.50&#x02009;&#x000b1;&#x02009;8.96</td><td align="center" valign="top" charoff="50">73.50&#x02009;&#x000b1;&#x02009;6.65</td><td align="center" valign="top" charoff="50">70.83&#x02009;&#x000b1;&#x02009;7.88</td></tr><tr><td align="left" valign="top" charoff="50">BMI, Kg/m<sup>2</sup></td><td align="center" valign="top" charoff="50">29.8&#x02009;&#x000b1;&#x02009;6.4</td><td align="center" valign="top" charoff="50">29.5&#x02009;&#x000b1;&#x02009;7.2</td><td align="center" valign="top" charoff="50">29.0&#x02009;&#x000b1;&#x02009;5.0</td><td align="center" valign="top" charoff="50">29.9&#x02009;&#x000b1;&#x02009;7.3</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t2"><label>Table 2</label><caption><title>Composition of total components contents of purslane seeds.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Peak #</th><th align="left" valign="top" charoff="50">Name</th><th align="center" valign="top" charoff="50">R.T. (s)</th><th align="center" valign="top" charoff="50">Area</th><th align="center" valign="top" charoff="50">Relative Amount (RA)</th><th align="center" valign="top" charoff="50">Mass</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">1</td><td align="left" valign="top" charoff="50">2-Propanol, 1-[(1-methylethyl) amino]-3-[2-(2-propenyl) phenoxy]-(Alprenolol, or alfeprol, alpheprol)</td><td align="center" valign="top" charoff="50">252.15</td><td align="center" valign="top" charoff="50">311449</td><td align="center" valign="top" charoff="50">0.04</td><td align="center" valign="top" charoff="50">249</td></tr><tr><td align="left" valign="top" charoff="50">2</td><td align="left" valign="top" charoff="50">4-Methylpiperidine-1-carboxylic acid, phenyl ester (acid amin3)</td><td align="center" valign="top" charoff="50">485.35</td><td align="center" valign="top" charoff="50">6340394</td><td align="center" valign="top" charoff="50">0.81</td><td align="center" valign="top" charoff="50">219</td></tr><tr><td align="left" valign="top" charoff="50">3</td><td align="left" valign="top" charoff="50">N-(1-Methoxycarbonyl-1-methylethyl)-4-methyl-2-aza-1,3-dioxane</td><td align="center" valign="top" charoff="50">582.25</td><td align="center" valign="top" charoff="50">4477291</td><td align="center" valign="top" charoff="50">0.57</td><td align="center" valign="top" charoff="50">203</td></tr><tr><td align="left" valign="top" charoff="50">4</td><td align="left" valign="top" charoff="50">Tetrahydropyran-4-ol, 2,2-dimethyl-4-[[(thiophen-2-ylmethyl) amino]methyl]-</td><td align="center" valign="top" charoff="50">717.9</td><td align="center" valign="top" charoff="50">129487357</td><td align="center" valign="top" charoff="50">16.61</td><td align="center" valign="top" charoff="50">255</td></tr><tr><td align="left" valign="top" charoff="50">5</td><td align="left" valign="top" charoff="50">1,3-Oxathiolane, 2-[[(2-chloroethyl) thio]methyl]-2-methyl-</td><td align="center" valign="top" charoff="50">736.3</td><td align="center" valign="top" charoff="50">388091</td><td align="center" valign="top" charoff="50">0.05</td><td align="center" valign="top" charoff="50">212</td></tr><tr><td align="left" valign="top" charoff="50">6</td><td align="left" valign="top" charoff="50">Benzoic acid, 2-(2-isopropyl-5-methylphenoxymethyl)-</td><td align="center" valign="top" charoff="50">853</td><td align="center" valign="top" charoff="50">6451312</td><td align="center" valign="top" charoff="50">0.83</td><td align="center" valign="top" charoff="50">284</td></tr><tr><td align="left" valign="top" charoff="50">7</td><td align="left" valign="top" charoff="50">29.82 Methyl dodecanoate</td><td align="center" valign="top" charoff="50">1684.55</td><td align="center" valign="top" charoff="50">2410439</td><td align="center" valign="top" charoff="50">0.31</td><td align="center" valign="top" charoff="50">214</td></tr><tr><td align="left" valign="top" charoff="50">8</td><td align="left" valign="top" charoff="50">n-Hexadecanoic acid (Palmitic acid)</td><td align="center" valign="top" charoff="50">1731.6</td><td align="center" valign="top" charoff="50">61905629</td><td align="center" valign="top" charoff="50">7.94</td><td align="center" valign="top" charoff="50">256</td></tr><tr><td align="left" valign="top" charoff="50">9</td><td align="left" valign="top" charoff="50">Decanamide, N-(2-hydroxyethyl)-</td><td align="center" valign="top" charoff="50">1925.3</td><td align="center" valign="top" charoff="50">52686347</td><td align="center" valign="top" charoff="50">6.76</td><td align="center" valign="top" charoff="50">215</td></tr><tr><td align="left" valign="top" charoff="50">10</td><td align="left" valign="top" charoff="50">9,12-Octadecadienoic acid (Z,Z)- Linoleic acid (LA)</td><td align="center" valign="top" charoff="50">1927.4</td><td align="center" valign="top" charoff="50">120792530</td><td align="center" valign="top" charoff="50">15.49</td><td align="center" valign="top" charoff="50">280</td></tr><tr><td align="left" valign="top" charoff="50">11</td><td align="left" valign="top" charoff="50">9-Hexadecenoic acid-(Palmitoleic acid)</td><td align="center" valign="top" charoff="50">1933.25</td><td align="center" valign="top" charoff="50">93736575</td><td align="center" valign="top" charoff="50">12.02</td><td align="center" valign="top" charoff="50">254</td></tr><tr><td align="left" valign="top" charoff="50">12</td><td align="left" valign="top" charoff="50">9,12,15-Octadecatrien-1-ol, (Z,Z,Z)-</td><td align="center" valign="top" charoff="50">1934.05</td><td align="center" valign="top" charoff="50">24934192</td><td align="center" valign="top" charoff="50">3.20</td><td align="center" valign="top" charoff="50">264</td></tr><tr><td align="left" valign="top" charoff="50">13</td><td align="left" valign="top" charoff="50">S-[2-[N,N-Dimethylamino]ethyl]N,N-dimethylcarbamoyl thiocarbohydroximate</td><td align="center" valign="top" charoff="50">2074.5</td><td align="center" valign="top" charoff="50">4196678</td><td align="center" valign="top" charoff="50">0.54</td><td align="center" valign="top" charoff="50">219</td></tr><tr><td align="left" valign="top" charoff="50">14</td><td align="left" valign="top" charoff="50">Palmidrol</td><td align="center" valign="top" charoff="50">2103.5</td><td align="center" valign="top" charoff="50">10489224</td><td align="center" valign="top" charoff="50">1.35</td><td align="center" valign="top" charoff="50">299</td></tr><tr><td align="left" valign="top" charoff="50">15</td><td align="left" valign="top" charoff="50">4-(7-Methoxy-7-methyloxepan-2-ylidene) butan-2-one</td><td align="center" valign="top" charoff="50">2110.3</td><td align="center" valign="top" charoff="50">5920620</td><td align="center" valign="top" charoff="50">0.76</td><td align="center" valign="top" charoff="50">212</td></tr><tr><td align="left" valign="top" charoff="50">16</td><td align="left" valign="top" charoff="50">6-Methoxy-2-methyl-quinoline-3-carboxylic acid 2-dimethylamino-ethyl ester</td><td align="center" valign="top" charoff="50">2240.95</td><td align="center" valign="top" charoff="50">16583058</td><td align="center" valign="top" charoff="50">2.13</td><td align="center" valign="top" charoff="50">288</td></tr><tr><td align="left" valign="top" charoff="50">17</td><td align="left" valign="top" charoff="50">Glycerol 1-palmitate</td><td align="center" valign="top" charoff="50">2292.1</td><td align="center" valign="top" charoff="50">24680340</td><td align="center" valign="top" charoff="50">3.17</td><td align="center" valign="top" charoff="50">330</td></tr><tr><td align="left" valign="top" charoff="50">18</td><td align="left" valign="top" charoff="50">Z-5,17-Octadecadien-1-ol acetate</td><td align="center" valign="top" charoff="50">2453.7</td><td align="center" valign="top" charoff="50">79862448</td><td align="center" valign="top" charoff="50">10.24</td><td align="center" valign="top" charoff="50">308</td></tr><tr><td align="left" valign="top" charoff="50">19</td><td align="left" valign="top" charoff="50">9,12,15-Octadecatrien-1-ol, (Z,Z,Z)-</td><td align="center" valign="top" charoff="50">2460.85</td><td align="center" valign="top" charoff="50">29437987</td><td align="center" valign="top" charoff="50">3.78</td><td align="center" valign="top" charoff="50">264</td></tr><tr><td align="left" valign="top" charoff="50">20</td><td align="left" valign="top" charoff="50">3H-Imidazo[4,5-b]pyridine, 2-(2-ethylhexylsulfanyl)-</td><td align="center" valign="top" charoff="50">2753</td><td align="center" valign="top" charoff="50">17494020</td><td align="center" valign="top" charoff="50">2.24</td><td align="center" valign="top" charoff="50">263</td></tr><tr><td align="left" valign="top" charoff="50">21</td><td align="left" valign="top" charoff="50">beta-Sitosterol</td><td align="center" valign="top" charoff="50">3004.8</td><td align="center" valign="top" charoff="50">87157789</td><td align="center" valign="top" charoff="50">11.18</td><td align="center" valign="top" charoff="50">414</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50"><bold>Total</bold></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50"><bold>779,743,770</bold></td><td align="center" valign="top" charoff="50"><bold>100</bold></td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t3"><label>Table 3</label><caption><title>Changes in the serum variables of diabetic subjects between 4 groups pre and post 16 weeks experiments.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Variable</th><th align="center" valign="top" charoff="50">Stage</th><th align="center" valign="top" charoff="50">Placebo (PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training&#x02009;+&#x02009;Placebo (AT&#x02009;+&#x02009;PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Purslane Seeds (PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training&#x02009;+&#x02009;Purslane Seeds (AT&#x02009;+&#x02009;PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="middle" charoff="50">Glucose, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">168.2&#x02009;&#x000b1;&#x02009;18.1</td><td align="center" valign="top" charoff="50">164.8&#x02009;&#x000b1;&#x02009;17.5</td><td align="center" valign="top" charoff="50">167.4&#x02009;&#x000b1;&#x02009;14.1</td><td align="center" valign="top" charoff="50">167.6&#x02009;&#x000b1;&#x02009;20.6</td></tr><tr><td align="center" valign="top" charoff="50">173.1&#x02009;&#x000b1;&#x02009;19.7</td><td align="center" valign="top" charoff="50">147.3&#x02009;&#x000b1;&#x02009;18.3<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,&#x02020;</sup></td><td align="center" valign="top" charoff="50">152.1&#x02009;&#x000b1;&#x02009;11.9<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">140.1&#x02009;&#x000b1;&#x02009;15.2<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">LDL-C, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">83.3&#x02009;&#x000b1;&#x02009;8.6</td><td align="center" valign="top" charoff="50">87.1&#x02009;&#x000b1;&#x02009;12.4</td><td align="center" valign="top" charoff="50">84.1&#x02009;&#x000b1;&#x02009;14.2</td><td align="center" valign="top" charoff="50">86.3&#x02009;&#x000b1;&#x02009;11.7</td></tr><tr><td align="center" valign="top" charoff="50">82.1&#x02009;&#x000b1;&#x02009;19.7</td><td align="center" valign="top" charoff="50">75.5&#x02009;&#x000b1;&#x02009;17.2<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">79.9&#x02009;&#x000b1;&#x02009;12.6<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">72.8&#x02009;&#x000b1;&#x02009;19.7<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">HDL-C, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">35.8&#x02009;&#x000b1;&#x02009;4.9</td><td align="center" valign="top" charoff="50">36.7&#x02009;&#x000b1;&#x02009;8.3</td><td align="center" valign="top" charoff="50">35.3&#x02009;&#x000b1;&#x02009;7.2</td><td align="center" valign="top" charoff="50">34.9&#x02009;&#x000b1;&#x02009;3.7</td></tr><tr><td align="center" valign="top" charoff="50">33.6&#x02009;&#x000b1;&#x02009;9.1</td><td align="center" valign="top" charoff="50">39.8&#x02009;&#x000b1;&#x02009;10.3<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">39.2&#x02009;&#x000b1;&#x02009;6.9<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">46.7&#x02009;&#x000b1;&#x02009;7.4<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">Cholesterol, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">197.2&#x02009;&#x000b1;&#x02009;22.4</td><td align="center" valign="top" charoff="50">198.5&#x02009;&#x000b1;&#x02009;26.1</td><td align="center" valign="top" charoff="50">196.9&#x02009;&#x000b1;&#x02009;22.6</td><td align="center" valign="top" charoff="50">198.7&#x02009;&#x000b1;&#x02009;24.8</td></tr><tr><td align="center" valign="top" charoff="50">209.2&#x02009;&#x000b1;&#x02009;20.1</td><td align="center" valign="top" charoff="50">169.7&#x02009;&#x000b1;&#x02009;14.8<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">172.3&#x02009;&#x000b1;&#x02009;19.3<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">155.2&#x02009;&#x000b1;&#x02009;16.4<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">TG, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">183.1&#x02009;&#x000b1;&#x02009;26.3</td><td align="center" valign="top" charoff="50">182.8&#x02009;&#x000b1;&#x02009;21.7</td><td align="center" valign="top" charoff="50">183.6&#x02009;&#x000b1;&#x02009;27.2</td><td align="center" valign="top" charoff="50">183.1&#x02009;&#x000b1;&#x02009;23.8</td></tr><tr><td align="center" valign="top" charoff="50">182.9&#x02009;&#x000b1;&#x02009;24.7</td><td align="center" valign="top" charoff="50">152.7&#x02009;&#x000b1;&#x02009;29.2<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">159.3&#x02009;&#x000b1;&#x02009;22.0<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">142.2&#x02009;&#x000b1;&#x02009;21.5<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">Creatinine, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">1.43&#x02009;&#x000b1;&#x02009;0.04</td><td align="center" valign="top" charoff="50">1.41&#x02009;&#x000b1;&#x02009;0.05</td><td align="center" valign="top" charoff="50">1.40&#x02009;&#x000b1;&#x02009;0.05</td><td align="center" valign="top" charoff="50">1.41&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td align="center" valign="top" charoff="50">1.43&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" valign="top" charoff="50">0.81&#x02009;&#x000b1;&#x02009;0.06<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">0.88&#x02009;&#x000b1;&#x02009;0.06<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">0.42&#x02009;&#x000b1;&#x02009;0.07<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">Urea, mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">19.31&#x02009;&#x000b1;&#x02009;1.19</td><td align="center" valign="top" charoff="50">18.99&#x02009;&#x000b1;&#x02009;1.04</td><td align="center" valign="top" charoff="50">18.86&#x02009;&#x000b1;&#x02009;0.82</td><td align="center" valign="top" charoff="50">19.01&#x02009;&#x000b1;&#x02009;0.63</td></tr><tr><td align="center" valign="top" charoff="50">19.31&#x02009;&#x000b1;&#x02009;1.11</td><td align="center" valign="top" charoff="50">14.21&#x02009;&#x000b1;&#x02009;0.98<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">14.42&#x02009;&#x000b1;&#x02009;0.07<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">10.62&#x02009;&#x000b1;&#x02009;0.98<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50">Uric Acid mg/dL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">4.65&#x02009;&#x000b1;&#x02009;0.15</td><td align="center" valign="top" charoff="50">4.82&#x02009;&#x000b1;&#x02009;0.18</td><td align="center" valign="top" charoff="50">4.59&#x02009;&#x000b1;&#x02009;0.16</td><td align="center" valign="top" charoff="50">4.71&#x02009;&#x000b1;&#x02009;0.15</td></tr><tr><td align="center" valign="top" charoff="50">4.66&#x02009;&#x000b1;&#x02009;0.42</td><td align="center" valign="top" charoff="50">3.38&#x02009;&#x000b1;&#x02009;0.21<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">3.11&#x02009;&#x000b1;&#x02009;0.14<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref></td><td align="center" valign="top" charoff="50">2.39&#x02009;&#x000b1;&#x02009;0.23<xref ref-type="fn" rid="t3-fn1">*</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn2">&#x02020;</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn3">#</xref><sup>,</sup><xref ref-type="fn" rid="t3-fn4">&#x02126;</xref></td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p><sup>*</sup>Denote significant differences from pre-test.</p></fn><fn id="t3-fn2"><p><sup>&#x02020;</sup>Denote significant differences from Placebo group.</p></fn><fn id="t3-fn3"><p><sup>#</sup>Denote significant differences from Aerobic Training+ Placebo.</p></fn><fn id="t3-fn4"><p><sup>&#x02126;</sup>Denote significant differences from Purslane Seeds group.</p></fn><fn id="t3-fn5"><p>p&#x02009;&#x0003c;&#x02009;0.05 as compared to pre-test, Placebo, Aerobic Training+ Placebo, and Purslane Seeds groups.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t4"><label>Table 4</label><caption><title>Changes in the Serum biomarkers concentration diabetic subjects between 4 groups pre and post 16 weeks experiments.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="center" valign="top" charoff="50">Variable</th><th align="center" valign="top" charoff="50">Stage</th><th align="center" valign="top" charoff="50">Placebo (PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training+ Placebo (AT&#x02009;+&#x02009;PL) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Purslane Seeds (PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th><th align="center" valign="top" charoff="50">Aerobic Training+Purslane Seeds (AT&#x02009;+&#x02009;PS) Mean&#x02009;&#x000b1;&#x02009;SEM</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="center" valign="middle" charoff="50">NF-&#x003ba;B1, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">8.74&#x02009;&#x000b1;&#x02009;0.7</td><td align="center" valign="top" charoff="50">8.87&#x02009;&#x000b1;&#x02009;0.5</td><td align="center" valign="top" charoff="50">8.52&#x02009;&#x000b1;&#x02009;0.5</td><td align="center" valign="top" charoff="50">8.79&#x02009;&#x000b1;&#x02009;0.6</td></tr><tr><td align="center" valign="top" charoff="50"> 8.69&#x02009;&#x000b1;&#x02009;0.2</td><td align="center" valign="top" charoff="50"> 6.7&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">6.5&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">5.3&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">GLP1, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">5.44&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" valign="top" charoff="50">4.38&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" valign="top" charoff="50">3.82&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" valign="top" charoff="50">3.43&#x02009;&#x000b1;&#x02009;0.3</td></tr><tr><td align="center" valign="top" charoff="50"> 5.55&#x02009;&#x000b1;&#x02009;0.4</td><td align="center" valign="top" charoff="50">5.78&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50"> 4.93&#x02009;&#x000b1;&#x02009;0.6<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref></td><td align="center" valign="top" charoff="50">5.77&#x02009;&#x000b1;&#x02009;0.7<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">GLP1-R, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">0.56&#x02009;&#x000b1;&#x02009;0.012</td><td align="center" valign="top" charoff="50">0.52&#x02009;&#x000b1;&#x02009;0.016</td><td align="center" valign="top" charoff="50">0.48&#x02009;&#x000b1;&#x02009;0.017</td><td align="center" valign="top" charoff="50">0.49&#x02009;&#x000b1;&#x02009;0.011</td></tr><tr><td align="center" valign="top" charoff="50"> 0.59&#x02009;&#x000b1;&#x02009;0.018</td><td align="center" valign="top" charoff="50">0.69&#x02009;&#x000b1;&#x02009;0.013<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50"> 0.67&#x02009;&#x000b1;&#x02009;0.015<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.71&#x02009;&#x000b1;&#x02009;0.014<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">TIMP-1, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">10.72&#x02009;&#x000b1;&#x02009;0.56</td><td align="center" valign="top" charoff="50">10.47&#x02009;&#x000b1;&#x02009;0.47</td><td align="center" valign="top" charoff="50">10.22&#x02009;&#x000b1;&#x02009;0.68</td><td align="center" valign="top" charoff="50">10.86&#x02009;&#x000b1;&#x02009;0.87</td></tr><tr><td align="center" valign="top" charoff="50">10.69&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" valign="top" charoff="50">6.98&#x02009;&#x000b1;&#x02009;0.95<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,&#x02020;,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">7.84&#x02009;&#x000b1;&#x02009;0.44<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref></td><td align="center" valign="top" charoff="50"> 5.12&#x02009;&#x000b1;&#x02009;0.65<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">MMP2, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">0.88&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" valign="top" charoff="50">0.87&#x02009;&#x000b1;&#x02009;0.03</td><td align="center" valign="top" charoff="50">0.88&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" valign="top" charoff="50">0.86&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td align="center" valign="top" charoff="50">0.87&#x02009;&#x000b1;&#x02009;0.03</td><td align="center" valign="top" charoff="50">0.70&#x02009;&#x000b1;&#x02009;0.04<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,&#x02020;,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.67&#x02009;&#x000b1;&#x02009;0.03<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.55&#x02009;&#x000b1;&#x02009;0.04<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">MMP9, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">1.62&#x02009;&#x000b1;&#x02009;0.05</td><td align="center" valign="top" charoff="50">1.59&#x02009;&#x000b1;&#x02009;0.07</td><td align="center" valign="top" charoff="50">1.58&#x02009;&#x000b1;&#x02009;0.08</td><td align="center" valign="top" charoff="50">1.60&#x02009;&#x000b1;&#x02009;0.07</td></tr><tr><td align="center" valign="top" charoff="50">1.61&#x02009;&#x000b1;&#x02009;0.04</td><td align="center" valign="top" charoff="50">1.08&#x02009;&#x000b1;&#x02009;0.22<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,&#x02020;,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" char="&#x000b1;" charoff="50">1.05&#x02009;&#x000b1;&#x02009;0.15<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.55&#x02009;&#x000b1;&#x02009;0.19<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">CRP, mg/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">8.72&#x02009;&#x000b1;&#x02009;0.4</td><td align="center" valign="top" charoff="50">7.91&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" valign="top" charoff="50">7.85&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" valign="top" charoff="50">8.56&#x02009;&#x000b1;&#x02009;0.7</td></tr><tr><td align="center" valign="top" charoff="50"> 8.83&#x02009;&#x000b1;&#x02009;0.5</td><td align="center" valign="top" charoff="50">6.1&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50"> 6.2&#x02009;&#x000b1;&#x02009;0.1<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50"> 5.1&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">CST3, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">35.13&#x02009;&#x000b1;&#x02009;4.32</td><td align="center" valign="top" charoff="50">35.33&#x02009;&#x000b1;&#x02009;3.52</td><td align="center" valign="top" charoff="50">34.71&#x02009;&#x000b1;&#x02009;4.61</td><td align="center" valign="top" charoff="50">34.51&#x02009;&#x000b1;&#x02009;3.22</td></tr><tr><td align="center" valign="top" charoff="50">35.75&#x02009;&#x000b1;&#x02009;3.25</td><td align="center" valign="top" charoff="50">26.25&#x02009;&#x000b1;&#x02009;3.95<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">25.98&#x02009;&#x000b1;&#x02009;2.44<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">20.09&#x02009;&#x000b1;&#x02009;3.65<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr><tr><td rowspan="2" align="center" valign="middle" charoff="50">CTSS, ng/mL</td><td rowspan="2" align="center" valign="middle" charoff="50">Pre Post</td><td align="center" valign="top" charoff="50">0.77&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" valign="top" charoff="50">0.76&#x02009;&#x000b1;&#x02009;0.03</td><td align="center" valign="top" charoff="50">0.79&#x02009;&#x000b1;&#x02009;0.06</td><td align="center" valign="top" charoff="50">0.79&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td align="center" valign="top" charoff="50">0.77&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" valign="top" charoff="50">0.64&#x02009;&#x000b1;&#x02009;0.05<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.61&#x02009;&#x000b1;&#x02009;0.02<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref></td><td align="center" valign="top" charoff="50">0.29&#x02009;&#x000b1;&#x02009;0.02<xref ref-type="fn" rid="t4-fn1">$</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn2">&#x003b2;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn3">&#x020ac;</xref><sup>,</sup><xref ref-type="fn" rid="t4-fn4">&#x000a3;</xref></td></tr></tbody></table><table-wrap-foot><fn id="t4-fn1"><p><sup>$</sup>Denote significant differences from pre-test.</p></fn><fn id="t4-fn2"><p><sup>&#x003b2;</sup>Denote significant differences from Placebo group.</p></fn><fn id="t4-fn3"><p><sup>&#x020ac;</sup>Denote significant differences from Aerobic Training+ Placebo.</p></fn><fn id="t4-fn4"><p><sup>&#x000a3;</sup>Denote significant differences from Purslane Seeds group.</p></fn><fn id="t4-fn5"><p>p&#x02009;&#x0003c;&#x02009;0.05 as compared to pre-test, Placebo, Aerobic Training+ Placebo, and Purslane Seeds groups.</p></fn></table-wrap-foot></table-wrap></floats-group></article>